Gene Symbol | Gene ID | Gene Info |
---|---|---|
E2F3
|
ENSG00000112242.10 | E2F transcription factor 3 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr6_20402144_20402837 | E2F3 | 92 | 0.964076 | 0.91 | 5.7e-04 | Click! |
chr6_20402885_20403426 | E2F3 | 757 | 0.609362 | 0.75 | 2.0e-02 | Click! |
chr6_20336872_20337023 | E2F3 | 65451 | 0.099723 | 0.71 | 3.1e-02 | Click! |
chr6_20401085_20401890 | E2F3 | 911 | 0.537818 | 0.70 | 3.7e-02 | Click! |
chr6_20404021_20405019 | E2F3 | 486 | 0.767926 | 0.66 | 5.1e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr8_2480609_2480797 | 2.63 |
MYOM2 |
myomesin 2 |
487519 |
0.01 |
chr16_88729806_88730180 | 1.56 |
SNAI3-AS1 |
SNAI3 antisense RNA 1 |
205 |
0.69 |
chr12_19592806_19593080 | 1.54 |
AEBP2 |
AE binding protein 2 |
310 |
0.92 |
chr12_2904145_2904429 | 1.43 |
FKBP4 |
FK506 binding protein 4, 59kDa |
168 |
0.92 |
chr2_151342286_151342580 | 1.37 |
RND3 |
Rho family GTPase 3 |
537 |
0.88 |
chr1_72748846_72749080 | 1.32 |
NEGR1 |
neuronal growth regulator 1 |
546 |
0.88 |
chr7_130418283_130418896 | 1.29 |
KLF14 |
Kruppel-like factor 14 |
299 |
0.92 |
chr1_55352544_55352822 | 1.26 |
RP11-67L3.5 |
|
135 |
0.55 |
chr10_131762010_131762251 | 1.25 |
EBF3 |
early B-cell factor 3 |
25 |
0.99 |
chr1_6662363_6662604 | 1.25 |
KLHL21 |
kelch-like family member 21 |
446 |
0.73 |
chr19_45888782_45889257 | 1.23 |
PPP1R13L |
protein phosphatase 1, regulatory subunit 13 like |
143 |
0.93 |
chr10_11865373_11865567 | 1.23 |
PROSER2 |
proline and serine-rich protein 2 |
73 |
0.98 |
chr7_17338358_17338529 | 1.22 |
AHR |
aryl hydrocarbon receptor |
197 |
0.69 |
chr16_49889200_49889463 | 1.22 |
ZNF423 |
zinc finger protein 423 |
715 |
0.75 |
chr6_150184570_150184721 | 1.20 |
RP11-244K5.8 |
|
15 |
0.89 |
chrX_19905153_19905596 | 1.20 |
SH3KBP1 |
SH3-domain kinase binding protein 1 |
203 |
0.96 |
chr10_126432668_126432895 | 1.18 |
FAM53B |
family with sequence similarity 53, member B |
57 |
0.97 |
chr4_170191374_170191525 | 1.17 |
SH3RF1 |
SH3 domain containing ring finger 1 |
341 |
0.93 |
chr18_7566824_7567068 | 1.16 |
PTPRM |
protein tyrosine phosphatase, receptor type, M |
166 |
0.97 |
chr12_71833497_71833776 | 1.16 |
LGR5 |
leucine-rich repeat containing G protein-coupled receptor 5 |
86 |
0.97 |
chr13_110960142_110960490 | 1.15 |
COL4A2 |
collagen, type IV, alpha 2 |
702 |
0.49 |
chr1_161102314_161102465 | 1.12 |
DEDD |
death effector domain containing |
11 |
0.93 |
chr12_33592297_33592879 | 1.11 |
SYT10 |
synaptotagmin X |
7 |
0.98 |
chr15_83680147_83680334 | 1.10 |
C15orf40 |
chromosome 15 open reading frame 40 |
97 |
0.92 |
chr20_3766238_3766588 | 1.10 |
CENPB |
centromere protein B, 80kDa |
924 |
0.35 |
chr14_105634190_105634406 | 1.10 |
JAG2 |
jagged 2 |
863 |
0.58 |
chr12_122064312_122064525 | 1.06 |
ORAI1 |
ORAI calcium release-activated calcium modulator 1 |
37 |
0.97 |
chr12_133264537_133264752 | 1.06 |
PXMP2 |
peroxisomal membrane protein 2, 22kDa |
9 |
0.48 |
chr11_120207222_120207426 | 1.05 |
ARHGEF12 |
Rho guanine nucleotide exchange factor (GEF) 12 |
463 |
0.81 |
chr7_79764314_79764804 | 1.04 |
GNAI1 |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 |
46 |
0.99 |
chr17_28705982_28706205 | 1.04 |
CPD |
carboxypeptidase D |
170 |
0.94 |
chr1_147624051_147624263 | 1.04 |
BX842679.1 |
Uncharacterized protein FLJ46360 |
8271 |
0.19 |
chr21_46293446_46293603 | 1.03 |
PTTG1IP |
pituitary tumor-transforming 1 interacting protein |
82 |
0.96 |
chr5_176036407_176036701 | 1.02 |
GPRIN1 |
G protein regulated inducer of neurite outgrowth 1 |
580 |
0.63 |
chr11_110167054_110167252 | 1.01 |
RDX |
radixin |
184 |
0.97 |
chr15_68118009_68118266 | 1.00 |
SKOR1 |
SKI family transcriptional corepressor 1 |
196 |
0.96 |
chr11_60673508_60673995 | 1.00 |
PRPF19 |
pre-mRNA processing factor 19 |
262 |
0.64 |
chr2_75787847_75788044 | 0.99 |
EVA1A |
eva-1 homolog A (C. elegans) |
94 |
0.97 |
chr8_38854817_38854968 | 0.99 |
ADAM9 |
ADAM metallopeptidase domain 9 |
387 |
0.57 |
chr14_90528183_90528389 | 0.98 |
KCNK13 |
potassium channel, subfamily K, member 13 |
177 |
0.97 |
chr5_55290485_55290723 | 0.98 |
IL6ST |
interleukin 6 signal transducer (gp130, oncostatin M receptor) |
188 |
0.72 |
chr19_6110825_6111002 | 0.98 |
RFX2 |
regulatory factor X, 2 (influences HLA class II expression) |
301 |
0.84 |
chr19_56988851_56989173 | 0.98 |
ZNF667 |
zinc finger protein 667 |
269 |
0.88 |
chr1_93250426_93250659 | 0.97 |
EVI5 |
ecotropic viral integration site 5 |
7409 |
0.17 |
chr11_35440658_35441040 | 0.97 |
SLC1A2 |
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
53 |
0.75 |
chr11_35641251_35641402 | 0.97 |
FJX1 |
four jointed box 1 (Drosophila) |
1591 |
0.46 |
chr8_26370640_26370791 | 0.96 |
PNMA2 |
paraneoplastic Ma antigen 2 |
893 |
0.46 |
chr19_19005707_19006262 | 0.96 |
GDF1 |
growth differentiation factor 1 |
921 |
0.31 |
chr11_66024836_66025065 | 0.96 |
KLC2 |
kinesin light chain 2 |
141 |
0.87 |
chr8_145581973_145582161 | 0.95 |
FBXL6 |
F-box and leucine-rich repeat protein 6 |
65 |
0.6 |
chr10_119303443_119303743 | 0.94 |
EMX2OS |
EMX2 opposite strand/antisense RNA |
986 |
0.44 |
chr2_223725769_223726044 | 0.94 |
ACSL3 |
acyl-CoA synthetase long-chain family member 3 |
162 |
0.97 |
chr3_184231133_184231441 | 0.94 |
EIF2B5-IT1 |
EIF2B5 intronic transcript 1 (non-protein coding) |
8386 |
0.19 |
chr5_32713152_32713703 | 0.93 |
NPR3 |
natriuretic peptide receptor C/guanylate cyclase C (atrionatriuretic peptide receptor C) |
990 |
0.65 |
chr16_12009232_12009428 | 0.93 |
GSPT1 |
G1 to S phase transition 1 |
263 |
0.47 |
chr5_7850951_7851446 | 0.93 |
C5orf49 |
chromosome 5 open reading frame 49 |
66 |
0.98 |
chr15_80987710_80987888 | 0.92 |
ABHD17C |
abhydrolase domain containing 17C |
147 |
0.96 |
chr1_36042833_36042984 | 0.92 |
RP4-728D4.2 |
|
422 |
0.78 |
chr11_63933058_63933366 | 0.91 |
MACROD1 |
MACRO domain containing 1 |
321 |
0.79 |
chr9_86322674_86322842 | 0.91 |
UBQLN1 |
ubiquilin 1 |
91 |
0.72 |
chr18_46477986_46478249 | 0.90 |
SMAD7 |
SMAD family member 7 |
1036 |
0.62 |
chr19_39904013_39904164 | 0.90 |
PLEKHG2 |
pleckstrin homology domain containing, family G (with RhoGef domain) member 2 |
80 |
0.92 |
chr7_90894763_90895064 | 0.90 |
FZD1 |
frizzled family receptor 1 |
1130 |
0.68 |
chr3_9974744_9974970 | 0.89 |
CRELD1 |
cysteine-rich with EGF-like domains 1 |
649 |
0.45 |
chr15_72767035_72767193 | 0.88 |
ARIH1 |
ariadne RBR E3 ubiquitin protein ligase 1 |
128 |
0.97 |
chr16_69372986_69373204 | 0.88 |
NIP7 |
NIP7, nucleolar pre-rRNA processing protein |
238 |
0.53 |
chr1_226250525_226250815 | 0.87 |
H3F3A |
H3 histone, family 3A |
255 |
0.86 |
chr1_153918834_153919140 | 0.87 |
DENND4B |
DENN/MADD domain containing 4B |
185 |
0.88 |
chr19_2096024_2096259 | 0.87 |
MOB3A |
MOB kinase activator 3A |
128 |
0.64 |
chr12_42876838_42877068 | 0.87 |
PRICKLE1 |
prickle homolog 1 (Drosophila) |
79 |
0.97 |
chr1_184723746_184723985 | 0.86 |
EDEM3 |
ER degradation enhancer, mannosidase alpha-like 3 |
164 |
0.96 |
chr1_50833981_50834192 | 0.86 |
DMRTA2 |
DMRT-like family A2 |
53218 |
0.15 |
chr19_11616618_11616769 | 0.86 |
ZNF653 |
zinc finger protein 653 |
45 |
0.95 |
chr5_175792593_175792998 | 0.86 |
ARL10 |
ADP-ribosylation factor-like 10 |
324 |
0.77 |
chr15_81293864_81294193 | 0.85 |
MESDC1 |
mesoderm development candidate 1 |
733 |
0.59 |
chr20_37555003_37555273 | 0.85 |
FAM83D |
family with sequence similarity 83, member D |
183 |
0.95 |
chr1_156829114_156829715 | 0.84 |
INSRR |
insulin receptor-related receptor |
604 |
0.55 |
chr16_65157518_65157704 | 0.84 |
CDH11 |
cadherin 11, type 2, OB-cadherin (osteoblast) |
1343 |
0.63 |
chr17_71161210_71161413 | 0.84 |
SSTR2 |
somatostatin receptor 2 |
160 |
0.95 |
chr3_129034345_129034731 | 0.84 |
H1FX-AS1 |
H1FX antisense RNA 1 |
175 |
0.82 |
chrX_48814848_48815217 | 0.84 |
OTUD5 |
OTU domain containing 5 |
139 |
0.9 |
chr2_87303324_87303568 | 0.83 |
PLGLB1 |
plasminogen-like B1 |
54471 |
0.15 |
chr11_554769_555059 | 0.83 |
RP11-496I9.1 |
|
2681 |
0.11 |
chr17_74382419_74382570 | 0.83 |
SPHK1 |
sphingosine kinase 1 |
1121 |
0.33 |
chr11_8289716_8290077 | 0.83 |
LMO1 |
LIM domain only 1 (rhombotin 1) |
367 |
0.91 |
chr3_185541992_185542409 | 0.83 |
IGF2BP2 |
insulin-like growth factor 2 mRNA binding protein 2 |
600 |
0.79 |
chr11_130184398_130184604 | 0.83 |
ZBTB44 |
zinc finger and BTB domain containing 44 |
6 |
0.98 |
chr19_48901834_48902054 | 0.82 |
GRIN2D |
glutamate receptor, ionotropic, N-methyl D-aspartate 2D |
3812 |
0.13 |
chr10_43951098_43951286 | 0.82 |
ENSG00000252532 |
. |
2321 |
0.26 |
chr6_91006489_91006667 | 0.82 |
BACH2 |
BTB and CNC homology 1, basic leucine zipper transcription factor 2 |
49 |
0.98 |
chr19_1205744_1205915 | 0.82 |
STK11 |
serine/threonine kinase 11 |
89 |
0.94 |
chr8_24814089_24814240 | 0.82 |
CTD-2168K21.2 |
|
29 |
0.98 |
chr3_194991581_194991897 | 0.82 |
XXYLT1 |
xyloside xylosyltransferase 1 |
157 |
0.95 |
chr19_19774541_19774793 | 0.82 |
ATP13A1 |
ATPase type 13A1 |
165 |
0.92 |
chr12_129307889_129308382 | 0.81 |
SLC15A4 |
solute carrier family 15 (oligopeptide transporter), member 4 |
68 |
0.98 |
chr10_15209880_15210157 | 0.81 |
NMT2 |
N-myristoyltransferase 2 |
427 |
0.86 |
chr4_171011215_171011473 | 0.81 |
AADAT |
aminoadipate aminotransferase |
21 |
0.99 |
chr16_75590196_75590347 | 0.81 |
TMEM231 |
transmembrane protein 231 |
87 |
0.95 |
chr19_18942831_18943151 | 0.81 |
UPF1 |
UPF1 regulator of nonsense transcripts homolog (yeast) |
181 |
0.93 |
chr6_35888676_35888903 | 0.81 |
SRPK1 |
SRSF protein kinase 1 |
35 |
0.98 |
chr13_25946609_25946813 | 0.80 |
ATP8A2 |
ATPase, aminophospholipid transporter, class I, type 8A, member 2 |
502 |
0.83 |
chr1_78148853_78149141 | 0.80 |
ZZZ3 |
zinc finger, ZZ-type containing 3 |
62 |
0.97 |
chr3_45883376_45883586 | 0.80 |
LZTFL1 |
leucine zipper transcription factor-like 1 |
127 |
0.96 |
chr12_80328300_80328629 | 0.80 |
PPP1R12A |
protein phosphatase 1, regulatory subunit 12A |
31 |
0.74 |
chr2_241938300_241938496 | 0.80 |
SNED1 |
sushi, nidogen and EGF-like domains 1 |
143 |
0.94 |
chr20_33865726_33865906 | 0.80 |
MMP24-AS1 |
MMP24 antisense RNA 1 |
14 |
0.59 |
chr9_137533577_137533991 | 0.80 |
COL5A1 |
collagen, type V, alpha 1 |
164 |
0.96 |
chr7_17338582_17338770 | 0.79 |
AC003075.4 |
|
305 |
0.61 |
chr2_233792112_233792317 | 0.79 |
NGEF |
neuronal guanine nucleotide exchange factor |
650 |
0.73 |
chr19_39616447_39616996 | 0.79 |
PAK4 |
p21 protein (Cdc42/Rac)-activated kinase 4 |
247 |
0.88 |
chr1_146082208_146082475 | 0.79 |
NBPF11 |
neuroblastoma breakpoint family, member 11 |
292 |
0.91 |
chr2_119981485_119981702 | 0.79 |
STEAP3 |
STEAP family member 3, metalloreductase |
164 |
0.96 |
chr6_117804579_117805184 | 0.79 |
DCBLD1 |
discoidin, CUB and LCCL domain containing 1 |
1056 |
0.49 |
chr6_36807429_36807833 | 0.79 |
CPNE5 |
copine V |
147 |
0.96 |
chr1_2574782_2574972 | 0.79 |
MMEL1 |
membrane metallo-endopeptidase-like 1 |
10396 |
0.15 |
chr16_2318889_2319040 | 0.78 |
RNPS1 |
RNA binding protein S1, serine-rich domain |
551 |
0.4 |
chr3_140770445_140770639 | 0.78 |
SPSB4 |
splA/ryanodine receptor domain and SOCS box containing 4 |
298 |
0.93 |
chr21_34697352_34697672 | 0.78 |
IFNAR1 |
interferon (alpha, beta and omega) receptor 1 |
234 |
0.93 |
chr8_2480347_2480513 | 0.78 |
MYOM2 |
myomesin 2 |
487246 |
0.01 |
chrX_44733071_44733237 | 0.78 |
KDM6A |
lysine (K)-specific demethylase 6A |
356 |
0.88 |
chr2_45878512_45878748 | 0.77 |
PRKCE |
protein kinase C, epsilon |
146 |
0.96 |
chr2_241526323_241526743 | 0.77 |
CAPN10 |
calpain 10 |
245 |
0.64 |
chr17_78120589_78120769 | 0.77 |
EIF4A3 |
eukaryotic translation initiation factor 4A3 |
259 |
0.9 |
chr1_41327679_41328070 | 0.77 |
CITED4 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4 |
144 |
0.94 |
chr6_79787718_79787933 | 0.77 |
PHIP |
pleckstrin homology domain interacting protein |
128 |
0.98 |
chr6_52529158_52529739 | 0.76 |
RP1-152L7.5 |
|
624 |
0.74 |
chr1_155293290_155293460 | 0.76 |
RUSC1 |
RUN and SH3 domain containing 1 |
353 |
0.56 |
chr2_48132779_48132937 | 0.76 |
AC079807.2 |
|
41 |
0.5 |
chr4_134067458_134067908 | 0.76 |
PCDH10 |
protocadherin 10 |
2787 |
0.44 |
chr3_14989325_14989581 | 0.76 |
FGD5-AS1 |
FGD5 antisense RNA 1 |
53 |
0.72 |
chr16_2961835_2962011 | 0.76 |
FLYWCH1 |
FLYWCH-type zinc finger 1 |
15 |
0.95 |
chr17_79370689_79371194 | 0.76 |
RP11-1055B8.6 |
Uncharacterized protein |
1666 |
0.23 |
chr9_19934576_19934968 | 0.76 |
ENSG00000266224 |
. |
105021 |
0.08 |
chr6_132272217_132272368 | 0.75 |
RP11-69I8.3 |
|
206 |
0.51 |
chr7_22396527_22396770 | 0.75 |
RAPGEF5 |
Rap guanine nucleotide exchange factor (GEF) 5 |
115 |
0.97 |
chrX_128657032_128657443 | 0.75 |
SMARCA1 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1 |
223 |
0.95 |
chr13_53029597_53029779 | 0.75 |
CKAP2 |
cytoskeleton associated protein 2 |
86 |
0.97 |
chr14_105558942_105559194 | 0.75 |
GPR132 |
G protein-coupled receptor 132 |
27286 |
0.15 |
chr4_6955592_6955760 | 0.75 |
TBC1D14 |
TBC1 domain family, member 14 |
271 |
0.75 |
chr22_29876820_29877133 | 0.74 |
NEFH |
neurofilament, heavy polypeptide |
757 |
0.55 |
chr2_75937833_75938047 | 0.74 |
GCFC2 |
GC-rich sequence DNA-binding factor 2 |
78 |
0.97 |
chr9_112542194_112542418 | 0.74 |
PALM2-AKAP2 |
PALM2-AKAP2 readthrough |
283 |
0.47 |
chr1_213224614_213224799 | 0.74 |
RPS6KC1 |
ribosomal protein S6 kinase, 52kDa, polypeptide 1 |
102 |
0.98 |
chr16_69221034_69221226 | 0.74 |
SNTB2 |
syntrophin, beta 2 (dystrophin-associated protein A1, 59kDa, basic component 2) |
98 |
0.95 |
chr19_575780_576366 | 0.74 |
BSG |
basigin (Ok blood group) |
852 |
0.39 |
chr4_122685749_122685967 | 0.74 |
AC079341.1 |
Uncharacterized protein |
118 |
0.81 |
chr9_127623706_127624170 | 0.74 |
RPL35 |
ribosomal protein L35 |
256 |
0.67 |
chr4_57842392_57842950 | 0.74 |
POLR2B |
polymerase (RNA) II (DNA directed) polypeptide B, 140kDa |
1217 |
0.37 |
chr1_205473407_205473583 | 0.74 |
CDK18 |
cyclin-dependent kinase 18 |
228 |
0.93 |
chr6_114179524_114179876 | 0.74 |
MARCKS |
myristoylated alanine-rich protein kinase C substrate |
1159 |
0.5 |
chr21_34851700_34852149 | 0.74 |
TMEM50B |
transmembrane protein 50B |
328 |
0.82 |
chr18_46476521_46476673 | 0.73 |
SMAD7 |
SMAD family member 7 |
197 |
0.96 |
chr2_232328935_232329147 | 0.73 |
NCL |
nucleolin |
123 |
0.93 |
chr1_33896442_33896692 | 0.73 |
PHC2 |
polyhomeotic homolog 2 (Drosophila) |
351 |
0.86 |
chr19_49497383_49497700 | 0.73 |
RUVBL2 |
RuvB-like AAA ATPase 2 |
375 |
0.6 |
chr9_140484605_140484793 | 0.73 |
ZMYND19 |
zinc finger, MYND-type containing 19 |
243 |
0.87 |
chr3_33759248_33759492 | 0.73 |
CLASP2 |
cytoplasmic linker associated protein 2 |
171 |
0.97 |
chr19_1275581_1275799 | 0.73 |
C19orf24 |
chromosome 19 open reading frame 24 |
255 |
0.81 |
chr2_208490362_208490613 | 0.72 |
METTL21A |
methyltransferase like 21A |
164 |
0.95 |
chr7_30029573_30029892 | 0.72 |
SCRN1 |
secernin 1 |
2 |
0.96 |
chrX_118370308_118370808 | 0.72 |
PGRMC1 |
progesterone receptor membrane component 1 |
270 |
0.94 |
chr5_178956987_178957198 | 0.72 |
RUFY1 |
RUN and FYVE domain containing 1 |
20467 |
0.17 |
chr3_184971593_184971833 | 0.72 |
EHHADH |
enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase |
106 |
0.9 |
chr2_98703049_98703523 | 0.72 |
VWA3B |
von Willebrand factor A domain containing 3B |
309 |
0.94 |
chr11_61560416_61560585 | 0.71 |
FADS2 |
fatty acid desaturase 2 |
48 |
0.42 |
chr2_165697959_165698374 | 0.71 |
COBLL1 |
cordon-bleu WH2 repeat protein-like 1 |
167 |
0.9 |
chr8_65494091_65494563 | 0.71 |
RP11-21C4.1 |
|
118 |
0.96 |
chr22_50699447_50699708 | 0.71 |
MAPK12 |
mitogen-activated protein kinase 12 |
160 |
0.89 |
chr1_85930427_85930699 | 0.71 |
DDAH1 |
dimethylarginine dimethylaminohydrolase 1 |
260 |
0.93 |
chr7_32982287_32982559 | 0.71 |
RP9P |
retinitis pigmentosa 9 pseudogene |
152 |
0.95 |
chr12_15942501_15942988 | 0.71 |
EPS8 |
epidermal growth factor receptor pathway substrate 8 |
234 |
0.96 |
chr16_67183969_67184120 | 0.71 |
B3GNT9 |
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9 |
1073 |
0.26 |
chr3_173114984_173115853 | 0.71 |
NLGN1 |
neuroligin 1 |
152 |
0.98 |
chr1_714267_714729 | 0.70 |
RP11-206L10.4 |
|
18207 |
0.13 |
chr3_141868396_141868547 | 0.70 |
TFDP2 |
transcription factor Dp-2 (E2F dimerization partner 2) |
85 |
0.97 |
chr4_187645131_187645294 | 0.70 |
FAT1 |
FAT atypical cadherin 1 |
203 |
0.97 |
chr19_8478096_8478249 | 0.70 |
MARCH2 |
membrane-associated ring finger (C3HC4) 2, E3 ubiquitin protein ligase |
2 |
0.95 |
chr1_87170463_87170736 | 0.70 |
SH3GLB1 |
SH3-domain GRB2-like endophilin B1 |
21 |
0.89 |
chr5_53813662_53813980 | 0.70 |
SNX18 |
sorting nexin 18 |
228 |
0.96 |
chr6_139014113_139014356 | 0.70 |
NHSL1 |
NHS-like 1 |
526 |
0.48 |
chr4_183066125_183066448 | 0.70 |
AC108142.1 |
|
116 |
0.64 |
chr6_136610579_136610864 | 0.70 |
BCLAF1 |
BCL2-associated transcription factor 1 |
198 |
0.95 |
chr12_120554771_120554980 | 0.70 |
RAB35 |
RAB35, member RAS oncogene family |
232 |
0.91 |
chr9_35072278_35072547 | 0.69 |
VCP |
valosin containing protein |
212 |
0.87 |
chr3_112931196_112931871 | 0.69 |
BOC |
BOC cell adhesion associated, oncogene regulated |
124 |
0.97 |
chr5_473388_473548 | 0.69 |
ENSG00000225138 |
. |
117 |
0.68 |
chr22_50689759_50689968 | 0.69 |
HDAC10 |
histone deacetylase 10 |
49 |
0.94 |
chr10_35931337_35931678 | 0.69 |
FZD8 |
frizzled family receptor 8 |
1145 |
0.38 |
chr1_14026830_14026981 | 0.69 |
PRDM2 |
PR domain containing 2, with ZNF domain |
170 |
0.95 |
chr20_19738276_19738696 | 0.69 |
AL121761.2 |
Uncharacterized protein |
193 |
0.95 |
chr2_10545385_10545610 | 0.69 |
HPCAL1 |
hippocalcin-like 1 |
14650 |
0.19 |
chr11_88070412_88070906 | 0.69 |
CTSC |
cathepsin C |
242 |
0.96 |
chr8_23386540_23386755 | 0.68 |
SLC25A37 |
solute carrier family 25 (mitochondrial iron transporter), member 37 |
74 |
0.97 |
chr17_60142459_60142618 | 0.68 |
MED13 |
mediator complex subunit 13 |
105 |
0.97 |
chr12_108522941_108523217 | 0.68 |
WSCD2 |
WSC domain containing 2 |
169 |
0.97 |
chr9_99212500_99212693 | 0.68 |
HABP4 |
hyaluronan binding protein 4 |
109 |
0.97 |
chr6_1390405_1390759 | 0.68 |
FOXF2 |
forkhead box F2 |
513 |
0.82 |
chr12_50451575_50451993 | 0.68 |
ASIC1 |
acid-sensing (proton-gated) ion channel 1 |
297 |
0.85 |
chr1_220921360_220921950 | 0.68 |
MARC2 |
mitochondrial amidoxime reducing component 2 |
21 |
0.98 |
chr22_31063979_31064207 | 0.68 |
DUSP18 |
dual specificity phosphatase 18 |
216 |
0.91 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 2.3 | GO:0010842 | retina layer formation(GO:0010842) |
0.6 | 1.7 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.5 | 2.5 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.5 | 1.4 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.5 | 3.8 | GO:0006554 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.5 | 0.9 | GO:0072216 | positive regulation of metanephros development(GO:0072216) |
0.5 | 2.3 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
0.4 | 1.3 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.4 | 1.3 | GO:0032351 | negative regulation of hormone metabolic process(GO:0032351) negative regulation of hormone biosynthetic process(GO:0032353) |
0.4 | 1.3 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.4 | 1.2 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.4 | 0.4 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
0.4 | 1.2 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.4 | 1.1 | GO:0035844 | cloaca development(GO:0035844) cloacal septation(GO:0060197) |
0.4 | 1.5 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.4 | 1.4 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.4 | 1.1 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.3 | 0.3 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.3 | 1.0 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
0.3 | 1.0 | GO:0071635 | negative regulation of transforming growth factor beta production(GO:0071635) |
0.3 | 1.0 | GO:0016559 | peroxisome fission(GO:0016559) |
0.3 | 1.3 | GO:0016266 | O-glycan processing(GO:0016266) |
0.3 | 1.0 | GO:0007144 | female meiosis I(GO:0007144) |
0.3 | 0.7 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.3 | 0.3 | GO:1901880 | regulation of actin filament depolymerization(GO:0030834) negative regulation of protein complex disassembly(GO:0043242) negative regulation of protein depolymerization(GO:1901880) |
0.3 | 0.9 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.3 | 1.2 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.3 | 1.2 | GO:0060437 | lung growth(GO:0060437) |
0.3 | 1.5 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.3 | 0.9 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.3 | 0.9 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
0.3 | 0.9 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
0.3 | 0.9 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.3 | 1.1 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.3 | 1.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.3 | 0.8 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.3 | 0.6 | GO:0072033 | renal vesicle formation(GO:0072033) |
0.3 | 0.5 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.3 | 0.8 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.3 | 0.8 | GO:0060502 | epithelial cell proliferation involved in lung morphogenesis(GO:0060502) |
0.3 | 0.5 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.3 | 0.8 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.3 | 0.8 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.3 | 1.3 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.3 | 0.8 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.3 | 2.0 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.3 | 1.0 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.3 | 0.8 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.2 | 1.0 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.2 | 0.7 | GO:0071428 | rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
0.2 | 0.2 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.2 | 0.2 | GO:0046398 | UDP-glucuronate biosynthetic process(GO:0006065) UDP-glucuronate metabolic process(GO:0046398) |
0.2 | 0.7 | GO:0090267 | positive regulation of spindle checkpoint(GO:0090232) regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) positive regulation of cell cycle checkpoint(GO:1901978) regulation of mitotic spindle checkpoint(GO:1903504) |
0.2 | 0.5 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.2 | 0.7 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.2 | 1.2 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.2 | 0.2 | GO:0006536 | glutamate metabolic process(GO:0006536) |
0.2 | 1.0 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.2 | 0.7 | GO:0016093 | polyprenol metabolic process(GO:0016093) dolichol metabolic process(GO:0019348) |
0.2 | 0.7 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.2 | 1.2 | GO:0046855 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
0.2 | 0.7 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
0.2 | 0.7 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.2 | 0.9 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) meiotic chromosome separation(GO:0051307) |
0.2 | 0.7 | GO:0022605 | oogenesis stage(GO:0022605) |
0.2 | 1.2 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.2 | 0.7 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.2 | 0.9 | GO:0019985 | translesion synthesis(GO:0019985) |
0.2 | 2.3 | GO:0060325 | face morphogenesis(GO:0060325) |
0.2 | 1.1 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.2 | 0.9 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.2 | 0.7 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.2 | 0.9 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.2 | 1.1 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.2 | 0.7 | GO:0001821 | histamine secretion(GO:0001821) |
0.2 | 0.7 | GO:0043497 | regulation of protein heterodimerization activity(GO:0043497) |
0.2 | 0.9 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.2 | 0.4 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.2 | 0.7 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.2 | 0.2 | GO:0045136 | development of secondary sexual characteristics(GO:0045136) |
0.2 | 0.4 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.2 | 0.7 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.2 | 1.1 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.2 | 0.6 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.2 | 0.6 | GO:0031507 | heterochromatin assembly(GO:0031507) heterochromatin organization(GO:0070828) |
0.2 | 0.6 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.2 | 0.6 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.2 | 1.0 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.2 | 0.6 | GO:0032071 | regulation of deoxyribonuclease activity(GO:0032070) regulation of endodeoxyribonuclease activity(GO:0032071) |
0.2 | 0.6 | GO:0072010 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.2 | 0.4 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.2 | 0.6 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.2 | 0.6 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.2 | 2.0 | GO:0051322 | anaphase(GO:0051322) |
0.2 | 0.6 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.2 | 0.6 | GO:0010626 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
0.2 | 0.2 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.2 | 0.8 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.2 | 1.4 | GO:0021854 | hypothalamus development(GO:0021854) |
0.2 | 1.0 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.2 | 0.6 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.2 | 0.2 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.2 | 1.0 | GO:0060039 | pericardium development(GO:0060039) |
0.2 | 0.4 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.2 | 0.6 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.2 | 3.1 | GO:0043631 | RNA polyadenylation(GO:0043631) |
0.2 | 0.6 | GO:0010159 | specification of organ position(GO:0010159) |
0.2 | 0.6 | GO:0002870 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) positive regulation of T cell anergy(GO:0002669) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) positive regulation of lymphocyte anergy(GO:0002913) |
0.2 | 0.4 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.2 | 0.6 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
0.2 | 0.2 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.2 | 1.4 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.2 | 0.6 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.2 | 0.8 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.2 | 0.9 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.2 | 0.6 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.2 | 0.6 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.2 | 0.6 | GO:0042117 | monocyte activation(GO:0042117) |
0.2 | 0.2 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.2 | 0.6 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.2 | 0.9 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.2 | 0.9 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.2 | 0.7 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.2 | 0.5 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.2 | 0.5 | GO:0001675 | acrosome assembly(GO:0001675) |
0.2 | 0.4 | GO:0032232 | negative regulation of actin filament bundle assembly(GO:0032232) |
0.2 | 0.4 | GO:0032722 | positive regulation of chemokine production(GO:0032722) |
0.2 | 0.7 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.2 | 0.4 | GO:1903020 | positive regulation of glycoprotein biosynthetic process(GO:0010560) positive regulation of glycoprotein metabolic process(GO:1903020) |
0.2 | 1.8 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.2 | 1.1 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.2 | 0.5 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.2 | 0.5 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.2 | 0.2 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.2 | 0.7 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.2 | 0.5 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.2 | 0.5 | GO:0032060 | bleb assembly(GO:0032060) |
0.2 | 1.6 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.2 | 0.5 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.2 | 0.5 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.2 | 0.5 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.2 | 0.3 | GO:0051590 | positive regulation of neurotransmitter transport(GO:0051590) |
0.2 | 0.5 | GO:0051583 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.2 | 0.5 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) |
0.2 | 0.5 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.2 | 0.9 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.2 | 0.9 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.2 | 1.0 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.2 | 0.7 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
0.2 | 0.2 | GO:0051608 | histamine transport(GO:0051608) |
0.2 | 0.5 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.2 | 0.5 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.2 | 0.5 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.2 | 0.3 | GO:0044268 | multicellular organismal protein catabolic process(GO:0044254) protein digestion(GO:0044256) multicellular organismal macromolecule catabolic process(GO:0044266) multicellular organismal protein metabolic process(GO:0044268) |
0.2 | 0.5 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.2 | 0.5 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.2 | 0.5 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.2 | 0.3 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.2 | 0.3 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.2 | 0.2 | GO:0060479 | lung cell differentiation(GO:0060479) lung epithelial cell differentiation(GO:0060487) |
0.2 | 0.5 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.2 | 0.5 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.2 | 0.2 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.2 | 0.6 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.2 | 0.9 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.2 | 0.8 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.2 | 0.5 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.2 | 3.1 | GO:0031111 | negative regulation of microtubule polymerization or depolymerization(GO:0031111) |
0.2 | 0.2 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.2 | 0.9 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.2 | 0.6 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
0.2 | 0.2 | GO:0060737 | prostate gland morphogenetic growth(GO:0060737) |
0.2 | 0.3 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.2 | 0.3 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.2 | 0.5 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.2 | 0.5 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.2 | 0.2 | GO:1900121 | regulation of receptor binding(GO:1900120) negative regulation of receptor binding(GO:1900121) |
0.2 | 0.8 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.2 | 1.1 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.2 | 0.2 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.2 | 0.2 | GO:0021834 | chemorepulsion involved in embryonic olfactory bulb interneuron precursor migration(GO:0021834) |
0.2 | 0.6 | GO:0045040 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.1 | 0.6 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.1 | 0.6 | GO:0060754 | mast cell chemotaxis(GO:0002551) regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) mast cell migration(GO:0097531) |
0.1 | 0.4 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.1 | 0.6 | GO:0070141 | response to UV-A(GO:0070141) |
0.1 | 1.0 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.1 | 0.7 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.1 | 0.1 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.1 | 1.2 | GO:1902603 | carnitine shuttle(GO:0006853) carnitine transmembrane transport(GO:1902603) |
0.1 | 0.3 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 0.9 | GO:0015780 | nucleotide-sugar transport(GO:0015780) |
0.1 | 0.4 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.1 | 0.4 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.1 | 0.4 | GO:0002063 | chondrocyte development(GO:0002063) |
0.1 | 0.6 | GO:0010916 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
0.1 | 1.1 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.1 | 0.6 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.1 | 4.4 | GO:0031124 | mRNA 3'-end processing(GO:0031124) |
0.1 | 0.3 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.1 | 0.3 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.1 | 2.7 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 0.6 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.1 | 0.6 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.1 | 1.0 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.1 | 0.4 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) establishment of spindle orientation(GO:0051294) |
0.1 | 0.1 | GO:0010988 | regulation of low-density lipoprotein particle clearance(GO:0010988) |
0.1 | 0.6 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.1 | 0.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.1 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.1 | 1.2 | GO:0007520 | syncytium formation by plasma membrane fusion(GO:0000768) myoblast fusion(GO:0007520) |
0.1 | 0.4 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.1 | 1.5 | GO:0097191 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
0.1 | 0.5 | GO:0032288 | myelin assembly(GO:0032288) |
0.1 | 0.3 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.1 | 0.4 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.1 | 0.5 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.1 | 0.7 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.1 | 0.3 | GO:0060897 | neural plate anterior/posterior regionalization(GO:0021999) neural plate regionalization(GO:0060897) |
0.1 | 1.1 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.7 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.1 | 0.4 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.1 | 0.3 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.1 | 0.3 | GO:0051155 | positive regulation of striated muscle cell differentiation(GO:0051155) |
0.1 | 1.1 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 0.1 | GO:2000178 | negative regulation of neuroblast proliferation(GO:0007406) negative regulation of neural precursor cell proliferation(GO:2000178) |
0.1 | 0.1 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.1 | 0.9 | GO:0033144 | negative regulation of intracellular steroid hormone receptor signaling pathway(GO:0033144) |
0.1 | 1.3 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.1 | 0.5 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.1 | 0.4 | GO:0009405 | pathogenesis(GO:0009405) |
0.1 | 0.5 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.1 | 0.5 | GO:0008218 | bioluminescence(GO:0008218) |
0.1 | 0.7 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
0.1 | 0.4 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 0.4 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.1 | 1.8 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.1 | 0.5 | GO:0031033 | myosin filament organization(GO:0031033) |
0.1 | 0.5 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.1 | 1.0 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.1 | 0.4 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.1 | 0.1 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.1 | 0.4 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 0.6 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.1 | 0.3 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.1 | 0.6 | GO:0080111 | DNA demethylation(GO:0080111) |
0.1 | 0.4 | GO:0045989 | positive regulation of striated muscle contraction(GO:0045989) |
0.1 | 0.4 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.1 | 0.6 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 0.6 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.1 | 0.4 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.1 | 0.6 | GO:0090559 | regulation of mitochondrial membrane permeability(GO:0046902) regulation of membrane permeability(GO:0090559) |
0.1 | 0.6 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.1 | 0.2 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.1 | 0.1 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.1 | 0.4 | GO:0007090 | obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
0.1 | 0.2 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.6 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.1 | 0.6 | GO:0042559 | pteridine-containing compound biosynthetic process(GO:0042559) |
0.1 | 0.5 | GO:0042921 | glucocorticoid receptor signaling pathway(GO:0042921) |
0.1 | 0.1 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.1 | 0.1 | GO:0002579 | positive regulation of antigen processing and presentation(GO:0002579) positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.1 | 0.4 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 0.1 | GO:0051383 | kinetochore organization(GO:0051383) |
0.1 | 3.1 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.1 | 0.6 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.1 | 1.2 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.1 | 0.2 | GO:1901976 | regulation of cell cycle checkpoint(GO:1901976) |
0.1 | 0.8 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) negative regulation of protein dephosphorylation(GO:0035308) |
0.1 | 1.1 | GO:0046326 | positive regulation of glucose import(GO:0046326) |
0.1 | 0.4 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.1 | 0.1 | GO:0051299 | centrosome separation(GO:0051299) |
0.1 | 0.5 | GO:0045780 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.1 | 0.6 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.1 | 1.1 | GO:0001960 | negative regulation of cytokine-mediated signaling pathway(GO:0001960) |
0.1 | 0.2 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.1 | 1.3 | GO:0007379 | segment specification(GO:0007379) |
0.1 | 0.4 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.1 | 0.5 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 0.2 | GO:0032909 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.1 | 0.1 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) DNA dealkylation(GO:0035510) |
0.1 | 0.3 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.1 | 0.5 | GO:0060736 | prostate gland growth(GO:0060736) |
0.1 | 0.1 | GO:0022038 | corpus callosum development(GO:0022038) |
0.1 | 0.3 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.1 | 1.3 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.1 | 0.5 | GO:0043102 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.1 | 0.5 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.1 | 0.1 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) |
0.1 | 0.2 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 0.2 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.1 | 0.2 | GO:0097094 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.1 | 0.3 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.1 | 0.3 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.1 | 1.1 | GO:0007006 | mitochondrial membrane organization(GO:0007006) |
0.1 | 0.1 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) |
0.1 | 1.0 | GO:1903311 | regulation of mRNA processing(GO:0050684) regulation of mRNA metabolic process(GO:1903311) |
0.1 | 0.5 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.1 | 0.1 | GO:0090116 | DNA methylation on cytosine(GO:0032776) C-5 methylation of cytosine(GO:0090116) |
0.1 | 0.4 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.1 | 0.1 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.3 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.1 | 0.2 | GO:0090281 | negative regulation of calcium ion import(GO:0090281) negative regulation of cation transmembrane transport(GO:1904063) |
0.1 | 0.2 | GO:0032966 | negative regulation of collagen biosynthetic process(GO:0032966) |
0.1 | 3.5 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) |
0.1 | 0.5 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.9 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.1 | 0.4 | GO:0031062 | positive regulation of histone methylation(GO:0031062) |
0.1 | 0.4 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.1 | 0.3 | GO:0031167 | rRNA methylation(GO:0031167) |
0.1 | 0.5 | GO:0032925 | regulation of activin receptor signaling pathway(GO:0032925) |
0.1 | 0.2 | GO:0002475 | antigen processing and presentation via MHC class Ib(GO:0002475) |
0.1 | 0.2 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.1 | 0.2 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.1 | 0.4 | GO:0043552 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.1 | 0.3 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 0.3 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 0.3 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.1 | 1.1 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.1 | 0.9 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) positive regulation of glycogen metabolic process(GO:0070875) |
0.1 | 0.1 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.1 | 0.4 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.1 | 0.4 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.1 | 0.9 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.1 | 1.1 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 0.2 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.1 | 0.4 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.1 | 0.4 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 1.2 | GO:0035967 | endoplasmic reticulum unfolded protein response(GO:0030968) cellular response to unfolded protein(GO:0034620) cellular response to topologically incorrect protein(GO:0035967) |
0.1 | 0.7 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.1 | 0.3 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 0.6 | GO:0000050 | urea cycle(GO:0000050) |
0.1 | 0.7 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.1 | 0.6 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.1 | 0.2 | GO:0090047 | obsolete positive regulation of transcription regulator activity(GO:0090047) |
0.1 | 0.4 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.1 | 0.4 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.1 | 0.1 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 0.6 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) metaphase plate congression(GO:0051310) |
0.1 | 0.3 | GO:0006530 | asparagine catabolic process(GO:0006530) asparagine catabolic process via L-aspartate(GO:0033345) |
0.1 | 0.6 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.8 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.5 | GO:1902668 | negative regulation of axon guidance(GO:1902668) |
0.1 | 0.2 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.1 | 0.2 | GO:0060049 | regulation of protein glycosylation(GO:0060049) |
0.1 | 0.1 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.1 | 2.7 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.1 | 0.4 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 0.7 | GO:0034644 | cellular response to UV(GO:0034644) |
0.1 | 0.5 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.6 | GO:0072666 | protein targeting to lysosome(GO:0006622) protein targeting to vacuole(GO:0006623) protein localization to lysosome(GO:0061462) protein localization to vacuole(GO:0072665) establishment of protein localization to vacuole(GO:0072666) |
0.1 | 2.0 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.3 | GO:0071636 | positive regulation of transforming growth factor beta production(GO:0071636) |
0.1 | 0.1 | GO:0031342 | negative regulation of cell killing(GO:0031342) |
0.1 | 0.4 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.1 | 0.6 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.1 | 0.1 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.1 | 0.3 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.3 | GO:0060174 | limb bud formation(GO:0060174) |
0.1 | 0.3 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.1 | 0.3 | GO:0008354 | germ cell migration(GO:0008354) |
0.1 | 0.6 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.1 | 0.3 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.1 | 0.4 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.1 | 2.9 | GO:0090090 | negative regulation of canonical Wnt signaling pathway(GO:0090090) |
0.1 | 0.4 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.1 | 0.6 | GO:0042069 | regulation of catecholamine metabolic process(GO:0042069) |
0.1 | 0.3 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.1 | 0.2 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) microtubule anchoring at microtubule organizing center(GO:0072393) |
0.1 | 1.3 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.1 | 0.1 | GO:0002407 | dendritic cell chemotaxis(GO:0002407) dendritic cell migration(GO:0036336) |
0.1 | 0.1 | GO:0010455 | positive regulation of cell fate commitment(GO:0010455) |
0.1 | 0.2 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 0.7 | GO:0016925 | protein sumoylation(GO:0016925) |
0.1 | 0.2 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 0.3 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.1 | 0.3 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.1 | 0.7 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.1 | 0.4 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.1 | 0.4 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.1 | 0.5 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.1 | 0.1 | GO:0048875 | surfactant homeostasis(GO:0043129) chemical homeostasis within a tissue(GO:0048875) |
0.1 | 0.5 | GO:0072676 | lymphocyte chemotaxis(GO:0048247) lymphocyte migration(GO:0072676) |
0.1 | 0.1 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.1 | 0.1 | GO:0006927 | obsolete transformed cell apoptotic process(GO:0006927) |
0.1 | 1.5 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.1 | 1.5 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.1 | 0.4 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.1 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.1 | 0.4 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.1 | 0.1 | GO:1903727 | positive regulation of lipid kinase activity(GO:0090218) positive regulation of phospholipid metabolic process(GO:1903727) |
0.1 | 0.2 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.1 | 0.1 | GO:0003057 | regulation of the force of heart contraction by chemical signal(GO:0003057) |
0.1 | 0.4 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 0.4 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.1 | 0.2 | GO:0002686 | negative regulation of leukocyte migration(GO:0002686) |
0.1 | 0.2 | GO:0007343 | egg activation(GO:0007343) |
0.1 | 1.3 | GO:1903320 | regulation of protein modification by small protein conjugation or removal(GO:1903320) |
0.1 | 0.3 | GO:0006448 | regulation of translational elongation(GO:0006448) |
0.1 | 0.1 | GO:0021602 | cranial nerve morphogenesis(GO:0021602) |
0.1 | 0.1 | GO:0060841 | venous blood vessel morphogenesis(GO:0048845) venous blood vessel development(GO:0060841) |
0.1 | 1.9 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.1 | 0.2 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.1 | 0.2 | GO:0060324 | face development(GO:0060324) |
0.1 | 0.1 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.1 | 0.2 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.1 | 1.1 | GO:0006739 | NADP metabolic process(GO:0006739) |
0.1 | 0.2 | GO:0050955 | sensory perception of temperature stimulus(GO:0050951) thermoception(GO:0050955) |
0.1 | 0.1 | GO:0021604 | cranial nerve structural organization(GO:0021604) facial nerve morphogenesis(GO:0021610) facial nerve structural organization(GO:0021612) |
0.1 | 0.1 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.1 | 0.2 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
0.1 | 0.5 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.1 | 0.1 | GO:0071503 | response to heparin(GO:0071503) |
0.1 | 0.2 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 0.2 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.1 | 0.6 | GO:0002021 | response to dietary excess(GO:0002021) |
0.1 | 0.2 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.1 | GO:0006562 | proline catabolic process(GO:0006562) |
0.1 | 0.1 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) |
0.1 | 0.4 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 0.2 | GO:0051882 | mitochondrial depolarization(GO:0051882) |
0.1 | 0.4 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.1 | 0.2 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.1 | 0.2 | GO:0052251 | induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) |
0.1 | 0.6 | GO:0006900 | membrane budding(GO:0006900) |
0.1 | 0.6 | GO:0006183 | GTP biosynthetic process(GO:0006183) UTP biosynthetic process(GO:0006228) CTP biosynthetic process(GO:0006241) pyrimidine nucleoside triphosphate biosynthetic process(GO:0009148) pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) UTP metabolic process(GO:0046051) |
0.1 | 0.2 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.1 | 0.3 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.1 | 2.3 | GO:0035966 | response to topologically incorrect protein(GO:0035966) |
0.1 | 0.2 | GO:0009065 | glutamine family amino acid catabolic process(GO:0009065) |
0.1 | 0.3 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.1 | 0.3 | GO:0015811 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.1 | 0.2 | GO:0010866 | regulation of triglyceride biosynthetic process(GO:0010866) |
0.1 | 0.7 | GO:0002209 | behavioral defense response(GO:0002209) |
0.1 | 0.5 | GO:0035082 | axoneme assembly(GO:0035082) |
0.1 | 0.4 | GO:2000738 | positive regulation of epithelial to mesenchymal transition(GO:0010718) positive regulation of stem cell differentiation(GO:2000738) |
0.1 | 0.4 | GO:0002823 | negative regulation of adaptive immune response(GO:0002820) negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains(GO:0002823) |
0.1 | 0.5 | GO:0007099 | centriole replication(GO:0007099) centriole assembly(GO:0098534) |
0.1 | 0.2 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 0.2 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 0.2 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 0.2 | GO:0071800 | podosome assembly(GO:0071800) |
0.1 | 0.1 | GO:0046502 | uroporphyrinogen III metabolic process(GO:0046502) |
0.1 | 0.2 | GO:0015802 | basic amino acid transport(GO:0015802) |
0.1 | 0.2 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.1 | 0.5 | GO:0034394 | protein localization to cell surface(GO:0034394) |
0.1 | 0.1 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.1 | 0.5 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.1 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.1 | 1.0 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.1 | 0.2 | GO:0045007 | depurination(GO:0045007) |
0.1 | 0.2 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 0.3 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.1 | 0.1 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.1 | 0.2 | GO:0006911 | phagocytosis, engulfment(GO:0006911) membrane invagination(GO:0010324) |
0.1 | 0.1 | GO:0006266 | DNA ligation(GO:0006266) |
0.1 | 0.2 | GO:0032506 | cytokinetic process(GO:0032506) |
0.1 | 2.4 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) |
0.1 | 4.7 | GO:0051028 | mRNA transport(GO:0051028) |
0.1 | 0.7 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.8 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.1 | 0.4 | GO:0009086 | methionine biosynthetic process(GO:0009086) |
0.1 | 0.1 | GO:0072599 | protein targeting to ER(GO:0045047) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.1 | 0.4 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.1 | 0.1 | GO:0090224 | regulation of mitotic spindle organization(GO:0060236) regulation of spindle organization(GO:0090224) |
0.1 | 0.4 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 0.4 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
0.1 | 0.5 | GO:0051353 | positive regulation of oxidoreductase activity(GO:0051353) |
0.1 | 0.1 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.1 | 0.9 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.1 | 0.2 | GO:0042177 | negative regulation of protein catabolic process(GO:0042177) |
0.1 | 0.5 | GO:0016577 | histone demethylation(GO:0016577) |
0.1 | 0.4 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.1 | 0.1 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.1 | 0.6 | GO:0010039 | response to iron ion(GO:0010039) |
0.1 | 0.1 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.1 | 0.1 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.1 | 0.8 | GO:0006997 | nucleus organization(GO:0006997) |
0.1 | 1.3 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 0.4 | GO:0030903 | notochord development(GO:0030903) |
0.1 | 0.1 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.1 | 0.1 | GO:0048596 | embryonic camera-type eye morphogenesis(GO:0048596) |
0.1 | 0.1 | GO:0032364 | oxygen homeostasis(GO:0032364) |
0.1 | 0.1 | GO:0043320 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
0.1 | 0.1 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 0.3 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.1 | 7.4 | GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
0.1 | 0.2 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.1 | 0.3 | GO:0001554 | luteolysis(GO:0001554) |
0.1 | 0.9 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.1 | 1.9 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.1 | 0.2 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.1 | 0.1 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.1 | 0.7 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.1 | 4.9 | GO:0006415 | translational termination(GO:0006415) |
0.1 | 0.3 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.1 | 0.1 | GO:0014874 | response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
0.1 | 0.2 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.1 | 0.3 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.1 | 0.2 | GO:0032727 | interferon-alpha production(GO:0032607) regulation of interferon-alpha production(GO:0032647) positive regulation of interferon-alpha production(GO:0032727) |
0.1 | 0.1 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.1 | 0.2 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.1 | 0.3 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.1 | 0.7 | GO:0042255 | ribosome assembly(GO:0042255) |
0.1 | 0.1 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.1 | 1.4 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.1 | 2.0 | GO:0015682 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
0.1 | 0.4 | GO:0001556 | oocyte maturation(GO:0001556) |
0.1 | 1.2 | GO:0034976 | response to endoplasmic reticulum stress(GO:0034976) |
0.1 | 0.1 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.1 | 0.6 | GO:0006662 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
0.1 | 0.1 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.1 | 0.6 | GO:0006302 | double-strand break repair(GO:0006302) |
0.1 | 0.1 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.1 | 0.1 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.1 | 1.8 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.1 | 0.3 | GO:0019695 | choline metabolic process(GO:0019695) |
0.1 | 0.1 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.1 | 0.6 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.1 | 0.1 | GO:0060998 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine development(GO:0060998) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.1 | 0.3 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.2 | GO:0010389 | regulation of G2/M transition of mitotic cell cycle(GO:0010389) regulation of cell cycle G2/M phase transition(GO:1902749) |
0.1 | 3.4 | GO:0000279 | M phase(GO:0000279) |
0.1 | 0.1 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.1 | 0.8 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.1 | 0.1 | GO:0002200 | somatic diversification of immune receptors(GO:0002200) |
0.1 | 0.3 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.1 | 0.2 | GO:0048087 | positive regulation of developmental pigmentation(GO:0048087) |
0.1 | 0.6 | GO:0032400 | melanosome localization(GO:0032400) |
0.1 | 5.0 | GO:0065004 | protein-DNA complex assembly(GO:0065004) |
0.1 | 0.2 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.1 | 0.3 | GO:0046006 | positive regulation of activated T cell proliferation(GO:0042104) regulation of activated T cell proliferation(GO:0046006) |
0.1 | 0.1 | GO:0071025 | RNA surveillance(GO:0071025) nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.1 | 0.2 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.1 | GO:0051298 | centrosome duplication(GO:0051298) |
0.1 | 0.2 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.1 | 0.2 | GO:0009129 | pyrimidine nucleoside monophosphate metabolic process(GO:0009129) |
0.1 | 0.1 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 0.6 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.5 | GO:0007140 | male meiosis(GO:0007140) |
0.1 | 0.1 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.1 | 0.2 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.1 | 0.2 | GO:0001820 | serotonin secretion(GO:0001820) |
0.1 | 0.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 0.3 | GO:0046689 | response to mercury ion(GO:0046689) |
0.1 | 0.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 0.1 | GO:0048261 | negative regulation of receptor-mediated endocytosis(GO:0048261) |
0.1 | 0.1 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.3 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.1 | 0.2 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.1 | 0.2 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.1 | 0.1 | GO:0014041 | regulation of neuron maturation(GO:0014041) regulation of cell maturation(GO:1903429) |
0.1 | 1.1 | GO:0006612 | protein targeting to membrane(GO:0006612) |
0.1 | 0.2 | GO:1902099 | regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
0.1 | 0.1 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.1 | 1.1 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.1 | 0.2 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.1 | 0.2 | GO:0050687 | negative regulation of defense response to virus(GO:0050687) negative regulation of defense response to virus by host(GO:0050689) |
0.1 | 0.2 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.1 | 0.2 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.1 | 0.7 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.1 | 0.3 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 0.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.1 | 0.5 | GO:0033189 | response to vitamin A(GO:0033189) |
0.1 | 0.2 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.1 | 0.1 | GO:0046718 | viral entry into host cell(GO:0046718) |
0.1 | 0.2 | GO:0015791 | polyol transport(GO:0015791) |
0.1 | 0.1 | GO:0006573 | valine metabolic process(GO:0006573) |
0.1 | 0.1 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.1 | 0.4 | GO:0030261 | chromosome condensation(GO:0030261) |
0.1 | 0.1 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 | 0.1 | GO:0001832 | blastocyst growth(GO:0001832) |
0.1 | 0.2 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.1 | 0.6 | GO:0001837 | epithelial to mesenchymal transition(GO:0001837) |
0.1 | 1.8 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) amino acid activation(GO:0043038) tRNA aminoacylation(GO:0043039) |
0.1 | 0.4 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
0.1 | 3.4 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.1 | 0.4 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 0.2 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.1 | 0.2 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 0.2 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.1 | 0.1 | GO:0033240 | positive regulation of cellular amine metabolic process(GO:0033240) |
0.1 | 0.1 | GO:0014821 | phasic smooth muscle contraction(GO:0014821) |
0.1 | 0.2 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 3.4 | GO:0000077 | DNA damage checkpoint(GO:0000077) |
0.1 | 0.2 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.1 | 0.1 | GO:0015853 | adenine transport(GO:0015853) |
0.1 | 0.7 | GO:0008272 | sulfate transport(GO:0008272) |
0.1 | 0.5 | GO:0051899 | membrane depolarization(GO:0051899) |
0.1 | 0.3 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
0.1 | 1.6 | GO:0006413 | translational initiation(GO:0006413) |
0.1 | 0.8 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.0 | 0.0 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.0 | 0.0 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.0 | 7.9 | GO:0006511 | ubiquitin-dependent protein catabolic process(GO:0006511) |
0.0 | 0.0 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.0 | 0.3 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.0 | 0.2 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.0 | 1.7 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.4 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
0.0 | 0.4 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.0 | 1.2 | GO:0006826 | iron ion transport(GO:0006826) |
0.0 | 0.7 | GO:0043928 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.0 | 0.1 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.0 | 0.7 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
0.0 | 0.3 | GO:0045022 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.0 | 0.2 | GO:0046040 | IMP biosynthetic process(GO:0006188) IMP metabolic process(GO:0046040) |
0.0 | 0.8 | GO:0019079 | viral genome replication(GO:0019079) |
0.0 | 0.0 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.0 | 0.0 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.0 | GO:1902667 | regulation of axon guidance(GO:1902667) |
0.0 | 0.0 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.0 | 0.2 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.0 | 0.0 | GO:0003283 | atrial septum development(GO:0003283) atrial septum morphogenesis(GO:0060413) |
0.0 | 0.2 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.0 | 0.1 | GO:0046885 | regulation of hormone biosynthetic process(GO:0046885) |
0.0 | 0.5 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.3 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.0 | 0.1 | GO:0034214 | protein hexamerization(GO:0034214) |
0.0 | 0.2 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.1 | GO:0009301 | snRNA transcription(GO:0009301) |
0.0 | 0.0 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.0 | 0.1 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.0 | 0.0 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.0 | 2.0 | GO:0030833 | regulation of actin filament polymerization(GO:0030833) |
0.0 | 0.0 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.0 | 0.0 | GO:0008214 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.0 | 0.1 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.0 | 0.3 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.0 | 0.1 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.0 | 0.2 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.0 | 0.2 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.0 | 0.2 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.0 | 0.3 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.0 | 0.0 | GO:0016322 | neuron remodeling(GO:0016322) |
0.0 | 0.1 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.0 | 0.2 | GO:0050850 | positive regulation of calcium-mediated signaling(GO:0050850) |
0.0 | 0.2 | GO:0065005 | protein-lipid complex assembly(GO:0065005) |
0.0 | 0.1 | GO:0051597 | response to methylmercury(GO:0051597) |
0.0 | 0.2 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.0 | 0.1 | GO:0006390 | mitochondrial RNA metabolic process(GO:0000959) transcription from mitochondrial promoter(GO:0006390) |
0.0 | 2.0 | GO:0006364 | rRNA processing(GO:0006364) |
0.0 | 0.6 | GO:0046854 | lipid phosphorylation(GO:0046834) phosphatidylinositol phosphorylation(GO:0046854) |
0.0 | 0.5 | GO:0051225 | spindle assembly(GO:0051225) |
0.0 | 3.6 | GO:0006457 | protein folding(GO:0006457) |
0.0 | 0.1 | GO:0006323 | DNA packaging(GO:0006323) |
0.0 | 0.1 | GO:0033014 | tetrapyrrole biosynthetic process(GO:0033014) |
0.0 | 4.2 | GO:0006184 | obsolete GTP catabolic process(GO:0006184) |
0.0 | 0.1 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
0.0 | 0.1 | GO:0045823 | positive regulation of heart contraction(GO:0045823) |
0.0 | 0.1 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
0.0 | 0.1 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.0 | 0.7 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 0.3 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 0.2 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.0 | 0.5 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
0.0 | 0.2 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.0 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 0.0 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.0 | 0.4 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
0.0 | 0.1 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) regulation of neutrophil migration(GO:1902622) |
0.0 | 0.1 | GO:0032610 | interleukin-1 alpha production(GO:0032610) |
0.0 | 0.1 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.0 | 0.2 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.0 | 0.1 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.0 | 0.1 | GO:0010935 | macrophage cytokine production(GO:0010934) regulation of macrophage cytokine production(GO:0010935) |
0.0 | 0.3 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
0.0 | 0.1 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.0 | 0.6 | GO:0048278 | vesicle docking(GO:0048278) |
0.0 | 3.9 | GO:0006470 | protein dephosphorylation(GO:0006470) |
0.0 | 0.2 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.0 | 0.3 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 | 0.0 | GO:0090312 | regulation of protein deacetylation(GO:0090311) positive regulation of protein deacetylation(GO:0090312) |
0.0 | 0.4 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.0 | 0.2 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) carnitine biosynthetic process(GO:0045329) |
0.0 | 0.0 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.0 | 0.3 | GO:0042094 | interleukin-2 biosynthetic process(GO:0042094) |
0.0 | 0.0 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.0 | 0.4 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.0 | 0.1 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.0 | 0.8 | GO:0006402 | mRNA catabolic process(GO:0006402) |
0.0 | 0.1 | GO:0006282 | regulation of DNA repair(GO:0006282) |
0.0 | 0.1 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 0.0 | GO:0002753 | cytoplasmic pattern recognition receptor signaling pathway(GO:0002753) nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.0 | 0.7 | GO:0006396 | RNA processing(GO:0006396) |
0.0 | 0.0 | GO:0045910 | negative regulation of DNA recombination(GO:0045910) |
0.0 | 0.1 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.0 | 0.3 | GO:0030239 | myofibril assembly(GO:0030239) |
0.0 | 0.1 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.0 | 0.1 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 | 0.3 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 0.0 | GO:0009756 | carbohydrate mediated signaling(GO:0009756) |
0.0 | 0.1 | GO:0006560 | proline metabolic process(GO:0006560) proline biosynthetic process(GO:0006561) |
0.0 | 0.1 | GO:0009084 | glutamine family amino acid biosynthetic process(GO:0009084) |
0.0 | 0.1 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.0 | 0.2 | GO:0032873 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
0.0 | 0.5 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.0 | 0.6 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.0 | 0.1 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.0 | 0.5 | GO:0030318 | melanocyte differentiation(GO:0030318) pigment cell differentiation(GO:0050931) |
0.0 | 0.0 | GO:0043931 | ossification involved in bone maturation(GO:0043931) organ maturation(GO:0048799) bone maturation(GO:0070977) |
0.0 | 0.0 | GO:0090501 | RNA phosphodiester bond hydrolysis(GO:0090501) |
0.0 | 0.1 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) negative regulation of translational initiation in response to stress(GO:0032057) |
0.0 | 1.3 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.0 | 0.4 | GO:0008633 | obsolete activation of pro-apoptotic gene products(GO:0008633) |
0.0 | 0.0 | GO:0021955 | central nervous system neuron axonogenesis(GO:0021955) |
0.0 | 2.3 | GO:0007160 | cell-matrix adhesion(GO:0007160) |
0.0 | 0.0 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.0 | 0.1 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.0 | 0.2 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.1 | GO:1902743 | regulation of lamellipodium organization(GO:1902743) |
0.0 | 0.3 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
0.0 | 0.1 | GO:0032365 | intracellular lipid transport(GO:0032365) |
0.0 | 0.0 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.0 | 0.1 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.1 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
0.0 | 0.0 | GO:0032350 | regulation of hormone metabolic process(GO:0032350) |
0.0 | 0.6 | GO:1901264 | carbohydrate derivative transport(GO:1901264) |
0.0 | 0.2 | GO:0007566 | embryo implantation(GO:0007566) |
0.0 | 0.1 | GO:0051452 | intracellular pH reduction(GO:0051452) |
0.0 | 0.1 | GO:0090208 | regulation of triglyceride catabolic process(GO:0010896) positive regulation of triglyceride catabolic process(GO:0010898) positive regulation of triglyceride metabolic process(GO:0090208) |
0.0 | 0.0 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.0 | 0.2 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.1 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.0 | 0.0 | GO:0060242 | contact inhibition(GO:0060242) |
0.0 | 0.1 | GO:0060291 | long-term synaptic potentiation(GO:0060291) |
0.0 | 1.7 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.0 | 0.2 | GO:0003407 | neural retina development(GO:0003407) |
0.0 | 0.1 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.0 | 0.1 | GO:1903318 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.0 | 0.4 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.3 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.0 | 0.0 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.0 | 0.0 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.0 | 0.2 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.0 | 0.2 | GO:0007030 | Golgi organization(GO:0007030) |
0.0 | 0.1 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) carnitine metabolic process(GO:0009437) |
0.0 | 1.0 | GO:1900274 | activation of phospholipase C activity(GO:0007202) positive regulation of phospholipase C activity(GO:0010863) regulation of phospholipase C activity(GO:1900274) |
0.0 | 0.1 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.0 | 0.0 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.0 | 0.1 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.0 | 0.1 | GO:0071384 | cellular response to corticosteroid stimulus(GO:0071384) cellular response to glucocorticoid stimulus(GO:0071385) |
0.0 | 2.6 | GO:0006397 | mRNA processing(GO:0006397) |
0.0 | 0.1 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.0 | 0.3 | GO:0016180 | snRNA metabolic process(GO:0016073) snRNA processing(GO:0016180) |
0.0 | 0.1 | GO:0021799 | cerebral cortex radially oriented cell migration(GO:0021799) |
0.0 | 0.0 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.0 | 0.0 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.0 | 0.2 | GO:0045740 | positive regulation of DNA replication(GO:0045740) |
0.0 | 0.1 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.0 | 0.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.0 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.0 | 0.1 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.1 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.0 | 0.0 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.0 | 0.1 | GO:0019941 | modification-dependent protein catabolic process(GO:0019941) modification-dependent macromolecule catabolic process(GO:0043632) |
0.0 | 0.1 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.0 | 0.1 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.0 | 0.0 | GO:0001302 | replicative cell aging(GO:0001302) |
0.0 | 0.1 | GO:0045822 | negative regulation of heart contraction(GO:0045822) |
0.0 | 0.1 | GO:0006337 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.0 | 0.1 | GO:0071600 | otic vesicle formation(GO:0030916) otic vesicle development(GO:0071599) otic vesicle morphogenesis(GO:0071600) |
0.0 | 0.0 | GO:0032049 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) phosphatidylglycerol metabolic process(GO:0046471) |
0.0 | 0.1 | GO:0006298 | mismatch repair(GO:0006298) |
0.0 | 0.0 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.0 | 0.1 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.0 | 0.2 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.0 | 0.0 | GO:0019884 | antigen processing and presentation of exogenous peptide antigen(GO:0002478) antigen processing and presentation of exogenous antigen(GO:0019884) |
0.0 | 0.2 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.1 | GO:2000379 | positive regulation of reactive oxygen species metabolic process(GO:2000379) |
0.0 | 0.1 | GO:0038061 | activation of NF-kappaB-inducing kinase activity(GO:0007250) NIK/NF-kappaB signaling(GO:0038061) regulation of NIK/NF-kappaB signaling(GO:1901222) positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
0.0 | 0.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.0 | 1.1 | GO:0006310 | DNA recombination(GO:0006310) |
0.0 | 0.3 | GO:0022613 | ribonucleoprotein complex biogenesis(GO:0022613) |
0.0 | 0.2 | GO:0051189 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.0 | 0.1 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.0 | 0.5 | GO:0034332 | adherens junction organization(GO:0034332) |
0.0 | 0.0 | GO:0000718 | nucleotide-excision repair, DNA damage removal(GO:0000718) DNA excision(GO:0044349) |
0.0 | 0.1 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.0 | 0.3 | GO:0006400 | tRNA modification(GO:0006400) |
0.0 | 0.4 | GO:0031638 | zymogen activation(GO:0031638) |
0.0 | 0.0 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.0 | 0.0 | GO:0007031 | peroxisome organization(GO:0007031) |
0.0 | 0.0 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.1 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.0 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.0 | 0.2 | GO:0006306 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.0 | 0.2 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
0.0 | 0.4 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.1 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.0 | 0.1 | GO:0006825 | copper ion transport(GO:0006825) |
0.0 | 0.1 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.0 | 0.0 | GO:0015748 | organophosphate ester transport(GO:0015748) |
0.0 | 0.4 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.0 | 0.0 | GO:0001974 | blood vessel remodeling(GO:0001974) |
0.0 | 0.0 | GO:0051451 | myoblast migration(GO:0051451) |
0.0 | 0.0 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) regulation of actin filament-based movement(GO:1903115) |
0.0 | 0.1 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.0 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.0 | 0.0 | GO:0051881 | regulation of mitochondrial membrane potential(GO:0051881) |
0.0 | 0.0 | GO:0010447 | response to acidic pH(GO:0010447) |
0.0 | 0.0 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.0 | 0.2 | GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) |
0.0 | 0.1 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.0 | 0.0 | GO:0043502 | regulation of muscle adaptation(GO:0043502) |
0.0 | 0.4 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.0 | 0.2 | GO:1901071 | glucosamine-containing compound metabolic process(GO:1901071) |
0.0 | 0.0 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.0 | 0.2 | GO:0035036 | binding of sperm to zona pellucida(GO:0007339) sperm-egg recognition(GO:0035036) |
0.0 | 0.5 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
0.0 | 0.0 | GO:0051875 | pigment granule localization(GO:0051875) |
0.0 | 0.1 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.0 | 0.0 | GO:1903019 | negative regulation of glycoprotein metabolic process(GO:1903019) |
0.0 | 1.7 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.1 | GO:0046688 | response to copper ion(GO:0046688) |
0.0 | 0.1 | GO:0033238 | regulation of cellular amino acid metabolic process(GO:0006521) regulation of cellular amine metabolic process(GO:0033238) |
0.0 | 0.0 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.0 | 0.4 | GO:0007602 | phototransduction(GO:0007602) |
0.0 | 0.1 | GO:1901678 | heme transport(GO:0015886) iron coordination entity transport(GO:1901678) |
0.0 | 0.2 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.0 | 0.0 | GO:0071436 | sodium ion export(GO:0071436) |
0.0 | 0.0 | GO:0048260 | positive regulation of receptor-mediated endocytosis(GO:0048260) |
0.0 | 0.6 | GO:0008033 | tRNA processing(GO:0008033) |
0.0 | 0.1 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.0 | 0.1 | GO:0008380 | RNA splicing(GO:0008380) |
0.0 | 0.2 | GO:0030149 | sphingolipid catabolic process(GO:0030149) |
0.0 | 0.1 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.0 | 0.1 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.0 | GO:0071569 | protein ufmylation(GO:0071569) |
0.0 | 0.0 | GO:0055062 | phosphate ion homeostasis(GO:0055062) divalent inorganic anion homeostasis(GO:0072505) trivalent inorganic anion homeostasis(GO:0072506) |
0.0 | 0.0 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.1 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.0 | 0.1 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.0 | 0.3 | GO:0070252 | actin-mediated cell contraction(GO:0070252) |
0.0 | 0.0 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.0 | 0.0 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.0 | 0.2 | GO:0098781 | ncRNA transcription(GO:0098781) |
0.0 | 0.4 | GO:0006914 | autophagy(GO:0006914) |
0.0 | 0.0 | GO:0034250 | positive regulation of cellular amide metabolic process(GO:0034250) |
0.0 | 0.0 | GO:0033028 | myeloid cell apoptotic process(GO:0033028) |
0.0 | 0.0 | GO:0050922 | negative regulation of chemotaxis(GO:0050922) |
0.0 | 0.1 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.0 | 0.0 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) negative regulation of cellular response to insulin stimulus(GO:1900077) |
0.0 | 0.0 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.0 | 1.1 | GO:0016032 | viral process(GO:0016032) |
0.0 | 0.1 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.0 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.0 | 0.0 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.0 | 0.2 | GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.0 | 0.1 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 1.5 | GO:0006412 | translation(GO:0006412) |
0.0 | 0.0 | GO:0048259 | regulation of receptor-mediated endocytosis(GO:0048259) |
0.0 | 0.0 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.0 | 0.0 | GO:0050856 | regulation of T cell receptor signaling pathway(GO:0050856) |
0.0 | 0.1 | GO:0030048 | actin filament-based movement(GO:0030048) |
0.0 | 0.0 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.0 | 0.2 | GO:0070585 | protein localization to mitochondrion(GO:0070585) |
0.0 | 0.1 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.0 | 0.0 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.0 | 0.0 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.0 | 0.0 | GO:0015870 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.0 | 0.0 | GO:0043248 | proteasome assembly(GO:0043248) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.9 | GO:0005827 | polar microtubule(GO:0005827) |
0.4 | 1.1 | GO:0072487 | MSL complex(GO:0072487) |
0.4 | 1.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.3 | 1.0 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.3 | 1.0 | GO:0043260 | laminin-11 complex(GO:0043260) |
0.3 | 1.2 | GO:0030056 | hemidesmosome(GO:0030056) |
0.3 | 0.8 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.3 | 1.4 | GO:0016589 | NURF complex(GO:0016589) |
0.3 | 2.1 | GO:0016342 | catenin complex(GO:0016342) |
0.3 | 0.8 | GO:0016939 | kinesin II complex(GO:0016939) |
0.2 | 2.0 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.2 | 1.4 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.2 | 0.7 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.2 | 1.1 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.2 | 0.5 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.2 | 0.2 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.2 | 0.9 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.2 | 0.9 | GO:0030891 | VCB complex(GO:0030891) |
0.2 | 1.1 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.2 | 1.3 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.2 | 0.8 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.2 | 0.8 | GO:0002178 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.2 | 0.6 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.2 | 1.2 | GO:0042382 | paraspeckles(GO:0042382) |
0.2 | 0.6 | GO:0000124 | SAGA complex(GO:0000124) |
0.2 | 1.0 | GO:0071437 | invadopodium(GO:0071437) |
0.2 | 0.6 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.2 | 1.7 | GO:0042555 | MCM complex(GO:0042555) |
0.2 | 0.4 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.2 | 0.2 | GO:0001940 | male pronucleus(GO:0001940) |
0.2 | 0.5 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.2 | 2.2 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.2 | 0.2 | GO:0097526 | U4/U6 x U5 tri-snRNP complex(GO:0046540) spliceosomal tri-snRNP complex(GO:0097526) |
0.2 | 1.0 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.2 | 1.0 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.2 | 1.8 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.2 | 0.2 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.2 | 4.2 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.2 | 0.6 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.2 | 1.8 | GO:0071564 | npBAF complex(GO:0071564) |
0.2 | 0.5 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.2 | 0.6 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.2 | 0.5 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 0.6 | GO:0032059 | bleb(GO:0032059) |
0.1 | 0.7 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 1.3 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 0.9 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 2.4 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.1 | 0.8 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.1 | 0.4 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 0.4 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.8 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.1 | 0.4 | GO:0031313 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.1 | 0.8 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 0.8 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 0.7 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.1 | 0.7 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 4.3 | GO:0042645 | mitochondrial nucleoid(GO:0042645) |
0.1 | 0.3 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 0.6 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.5 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 0.4 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.1 | 1.0 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.7 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 2.7 | GO:0032421 | stereocilium bundle(GO:0032421) |
0.1 | 0.5 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.1 | 0.5 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 0.6 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 0.6 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.1 | 6.9 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.1 | 2.1 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 0.7 | GO:0005682 | U5 snRNP(GO:0005682) |
0.1 | 0.8 | GO:0005683 | U7 snRNP(GO:0005683) |
0.1 | 0.5 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.7 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 0.6 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 3.6 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 1.0 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 1.0 | GO:0014704 | intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.1 | 0.1 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
0.1 | 0.3 | GO:0001950 | obsolete plasma membrane enriched fraction(GO:0001950) |
0.1 | 0.6 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 0.7 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.1 | 0.3 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.1 | 0.4 | GO:0070820 | tertiary granule(GO:0070820) |
0.1 | 0.9 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
0.1 | 1.0 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 0.4 | GO:0000792 | heterochromatin(GO:0000792) |
0.1 | 0.3 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.1 | 0.3 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 1.4 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.1 | 0.6 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 1.7 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.6 | GO:0005652 | nuclear lamina(GO:0005652) |
0.1 | 0.2 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 3.0 | GO:0034708 | methyltransferase complex(GO:0034708) histone methyltransferase complex(GO:0035097) |
0.1 | 1.2 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.1 | 0.7 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.7 | GO:0030677 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.1 | 0.4 | GO:0042583 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
0.1 | 5.9 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.1 | 0.4 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.1 | 0.4 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.1 | 0.5 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 0.5 | GO:0016580 | Sin3 complex(GO:0016580) Sin3-type complex(GO:0070822) |
0.1 | 0.5 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 0.2 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 0.7 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 0.2 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 0.7 | GO:0016585 | obsolete chromatin remodeling complex(GO:0016585) |
0.1 | 1.4 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 0.1 | GO:0000785 | chromatin(GO:0000785) |
0.1 | 0.7 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.1 | 0.5 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 1.0 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.1 | 0.4 | GO:0042825 | TAP complex(GO:0042825) |
0.1 | 0.3 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 0.3 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 1.6 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 3.6 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 0.2 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
0.1 | 0.3 | GO:0033268 | node of Ranvier(GO:0033268) |
0.1 | 0.9 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 1.6 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.1 | 0.9 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.1 | 0.4 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 0.3 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.1 | 0.6 | GO:0005844 | polysome(GO:0005844) |
0.1 | 0.6 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 1.1 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 0.9 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 2.9 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.1 | 0.3 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.1 | 0.3 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 1.5 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 0.7 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.1 | 0.4 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 0.3 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.7 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 0.6 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.1 | 2.3 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 3.7 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 2.7 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 0.3 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 0.2 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 2.2 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.1 | 0.4 | GO:0000776 | kinetochore(GO:0000776) |
0.1 | 0.5 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 0.2 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.1 | 0.2 | GO:0071565 | nBAF complex(GO:0071565) |
0.1 | 2.8 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.1 | 0.5 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 0.4 | GO:0030897 | HOPS complex(GO:0030897) |
0.1 | 0.4 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.1 | 0.1 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.1 | 0.7 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.1 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.1 | 4.2 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 0.5 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.1 | 0.7 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 0.1 | GO:0000800 | lateral element(GO:0000800) |
0.1 | 0.3 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 0.5 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 3.9 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 3.9 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 0.8 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.1 | 0.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.1 | 0.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 0.2 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 0.2 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 0.3 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 0.5 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.2 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 0.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 3.6 | GO:0030427 | site of polarized growth(GO:0030427) |
0.1 | 0.2 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.1 | 1.1 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.1 | 7.0 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.1 | 2.3 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 3.1 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 0.3 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 0.3 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 0.8 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 0.1 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.1 | 0.5 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 3.5 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 0.4 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 0.6 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.1 | 0.5 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 1.1 | GO:0016234 | inclusion body(GO:0016234) |
0.1 | 0.6 | GO:0043073 | germ cell nucleus(GO:0043073) |
0.1 | 2.9 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.1 | 0.1 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) |
0.1 | 0.9 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 0.1 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.1 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.1 | 4.3 | GO:0019717 | obsolete synaptosome(GO:0019717) |
0.1 | 0.2 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.1 | 0.2 | GO:0033011 | perinuclear theca(GO:0033011) |
0.1 | 1.7 | GO:0031514 | motile cilium(GO:0031514) |
0.1 | 0.1 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 0.2 | GO:0005749 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.1 | 4.2 | GO:0016607 | nuclear speck(GO:0016607) |
0.1 | 0.1 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.1 | 1.2 | GO:0042641 | actomyosin(GO:0042641) |
0.1 | 0.4 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.1 | 3.1 | GO:0000786 | nucleosome(GO:0000786) |
0.1 | 0.4 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 0.4 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.1 | 5.0 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.1 | 0.8 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 0.4 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 0.7 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 2.3 | GO:0060205 | cytoplasmic membrane-bounded vesicle lumen(GO:0060205) |
0.1 | 0.7 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.1 | 0.1 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.1 | 0.2 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 0.2 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.0 | 3.9 | GO:0031965 | nuclear membrane(GO:0031965) |
0.0 | 0.7 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 1.8 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.2 | GO:0000796 | condensin complex(GO:0000796) |
0.0 | 0.1 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.3 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.0 | 0.4 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.1 | GO:0070552 | BRISC complex(GO:0070552) |
0.0 | 1.2 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.0 | 0.6 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 0.2 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.0 | 0.2 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.0 | 1.7 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.0 | 4.2 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 0.1 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 0.0 | GO:0000125 | PCAF complex(GO:0000125) |
0.0 | 0.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 0.4 | GO:0016528 | sarcoplasm(GO:0016528) |
0.0 | 4.9 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 0.4 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 0.1 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.0 | 5.5 | GO:1990904 | intracellular ribonucleoprotein complex(GO:0030529) ribonucleoprotein complex(GO:1990904) |
0.0 | 1.1 | GO:0005814 | centriole(GO:0005814) |
0.0 | 0.4 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.0 | 0.5 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.0 | 0.4 | GO:0030135 | coated vesicle(GO:0030135) |
0.0 | 6.2 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 1.5 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.0 | 0.4 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.2 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 0.9 | GO:0070469 | respiratory chain(GO:0070469) |
0.0 | 0.1 | GO:0032432 | actin filament bundle(GO:0032432) |
0.0 | 0.6 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.4 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.0 | 0.6 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 0.1 | GO:0001741 | XY body(GO:0001741) |
0.0 | 0.2 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.1 | GO:0032449 | CBM complex(GO:0032449) |
0.0 | 0.2 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.0 | 0.8 | GO:0031902 | late endosome membrane(GO:0031902) |
0.0 | 0.0 | GO:0031904 | endosome lumen(GO:0031904) |
0.0 | 2.6 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.0 | 0.5 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.3 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.8 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.0 | 0.4 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.2 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 22.6 | GO:0005730 | nucleolus(GO:0005730) |
0.0 | 0.5 | GO:0031970 | organelle envelope lumen(GO:0031970) |
0.0 | 0.8 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.2 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.1 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.0 | 14.1 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 0.6 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 0.6 | GO:0034704 | calcium channel complex(GO:0034704) |
0.0 | 0.3 | GO:0000123 | histone acetyltransferase complex(GO:0000123) protein acetyltransferase complex(GO:0031248) acetyltransferase complex(GO:1902493) |
0.0 | 0.3 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 76.3 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 0.0 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.0 | 0.1 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 7.5 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.0 | 0.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 0.7 | GO:0005938 | cell cortex(GO:0005938) |
0.0 | 2.1 | GO:0005874 | microtubule(GO:0005874) |
0.0 | 0.0 | GO:0031983 | vesicle lumen(GO:0031983) |
0.0 | 0.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.0 | 0.2 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 0.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 0.0 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.0 | 0.0 | GO:0030990 | intraciliary transport particle(GO:0030990) intraciliary transport particle B(GO:0030992) |
0.0 | 0.4 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 0.1 | GO:0016272 | prefoldin complex(GO:0016272) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.6 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.5 | 1.5 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
0.5 | 0.9 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.5 | 1.4 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.4 | 2.3 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.4 | 1.1 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.4 | 1.4 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.3 | 1.4 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.3 | 1.0 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.3 | 1.3 | GO:0048495 | Roundabout binding(GO:0048495) |
0.3 | 1.2 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.3 | 1.8 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.3 | 1.2 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.3 | 0.9 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.3 | 0.9 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.3 | 0.9 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.3 | 1.2 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.3 | 3.0 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.3 | 1.5 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.3 | 0.3 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.3 | 0.9 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.3 | 2.0 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.3 | 0.8 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.3 | 1.4 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.3 | 0.8 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.3 | 3.0 | GO:0048185 | activin binding(GO:0048185) |
0.3 | 0.8 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.3 | 0.8 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.3 | 1.3 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.3 | 0.5 | GO:0070061 | fructose binding(GO:0070061) |
0.2 | 1.0 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.2 | 0.5 | GO:0034648 | histone demethylase activity (H3-K4 specific)(GO:0032453) histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.2 | 0.5 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.2 | 0.9 | GO:0030172 | troponin C binding(GO:0030172) |
0.2 | 0.9 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.2 | 0.9 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.2 | 0.7 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.2 | 1.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.2 | 0.9 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.2 | 2.2 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.2 | 1.1 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.2 | 0.7 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.2 | 1.3 | GO:0005521 | lamin binding(GO:0005521) |
0.2 | 0.6 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.2 | 0.6 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.2 | 0.6 | GO:0051734 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.2 | 0.2 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.2 | 0.6 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.2 | 1.0 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
0.2 | 0.6 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.2 | 1.2 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.2 | 1.0 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.2 | 0.4 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.2 | 0.2 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.2 | 0.8 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.2 | 0.6 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.2 | 0.6 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.2 | 2.2 | GO:0030275 | LRR domain binding(GO:0030275) |
0.2 | 1.8 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.2 | 0.4 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) adenyl deoxyribonucleotide binding(GO:0032558) |
0.2 | 1.0 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 0.6 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.2 | 0.8 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.2 | 1.1 | GO:0061659 | ubiquitin-ubiquitin ligase activity(GO:0034450) ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.2 | 0.9 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.2 | 0.8 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.2 | 3.6 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) |
0.2 | 1.1 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.2 | 0.6 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
0.2 | 0.6 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.2 | 0.7 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.2 | 0.5 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.2 | 0.7 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.2 | 0.7 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.2 | 0.7 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.2 | 1.9 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.2 | 0.5 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.2 | 0.7 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.2 | 0.5 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.2 | 0.5 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.2 | 1.4 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.2 | 0.7 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.2 | 0.2 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.2 | 0.5 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.2 | 1.5 | GO:0016566 | obsolete specific transcriptional repressor activity(GO:0016566) |
0.2 | 0.5 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.2 | 0.5 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.2 | 0.5 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.2 | 1.1 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.2 | 1.2 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 0.2 | GO:0003704 | obsolete specific RNA polymerase II transcription factor activity(GO:0003704) |
0.2 | 0.9 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.2 | 0.8 | GO:0005351 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
0.2 | 0.5 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.2 | 0.9 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.2 | 0.5 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.1 | 0.9 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.1 | 0.7 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 2.6 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.1 | 0.4 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.1 | 1.5 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.4 | GO:0031404 | chloride ion binding(GO:0031404) |
0.1 | 0.6 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.7 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 0.6 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
0.1 | 0.8 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 0.7 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 1.4 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.1 | 1.5 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 1.0 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.8 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.1 | 0.4 | GO:0004802 | transketolase activity(GO:0004802) |
0.1 | 0.4 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.1 | 0.4 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.1 | 0.8 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 0.4 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 3.2 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 0.5 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.1 | 0.8 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 0.8 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 2.5 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.1 | 1.4 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.5 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 0.3 | GO:0003896 | DNA primase activity(GO:0003896) |
0.1 | 0.6 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 0.1 | GO:0017002 | activin receptor activity, type I(GO:0016361) activin-activated receptor activity(GO:0017002) |
0.1 | 0.5 | GO:0045569 | TRAIL binding(GO:0045569) |
0.1 | 0.4 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 1.1 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.4 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.1 | 0.4 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.1 | 0.7 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 0.2 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.1 | 0.4 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.1 | 1.1 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.1 | 0.4 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.6 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.1 | 0.4 | GO:0031013 | troponin I binding(GO:0031013) |
0.1 | 0.9 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.1 | 1.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.6 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.1 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.1 | 0.1 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
0.1 | 0.8 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.1 | 0.4 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.1 | 1.4 | GO:0015645 | fatty acid ligase activity(GO:0015645) |
0.1 | 0.5 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 0.6 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.1 | 0.4 | GO:0004739 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.1 | 0.5 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.1 | 0.2 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.1 | 0.4 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.1 | 0.7 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.1 | 0.3 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 0.7 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 0.3 | GO:0002054 | nucleobase binding(GO:0002054) purine nucleobase binding(GO:0002060) |
0.1 | 0.7 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.1 | 1.0 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 0.5 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.3 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 1.4 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.1 | 0.3 | GO:0004803 | transposase activity(GO:0004803) |
0.1 | 0.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.1 | 2.0 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.7 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.1 | 0.7 | GO:0004437 | obsolete inositol or phosphatidylinositol phosphatase activity(GO:0004437) |
0.1 | 1.4 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 1.2 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.1 | 0.5 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.1 | 0.8 | GO:0030332 | cyclin binding(GO:0030332) |
0.1 | 1.0 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.1 | 0.3 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 0.3 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 0.4 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.1 | 1.0 | GO:0017069 | snRNA binding(GO:0017069) |
0.1 | 0.2 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 0.3 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 0.3 | GO:0015184 | sulfur amino acid transmembrane transporter activity(GO:0000099) L-cystine transmembrane transporter activity(GO:0015184) |
0.1 | 3.0 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.1 | 0.7 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 0.4 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 0.7 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 0.1 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.1 | 0.5 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.1 | 0.4 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 2.6 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.1 | 3.9 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 1.3 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.5 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.3 | GO:0016531 | copper chaperone activity(GO:0016531) |
0.1 | 0.3 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.1 | 0.5 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 0.2 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.4 | GO:0016847 | 1-aminocyclopropane-1-carboxylate synthase activity(GO:0016847) |
0.1 | 0.9 | GO:0042171 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.1 | 0.4 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 0.6 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 0.3 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 1.6 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 0.6 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.4 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 0.3 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.1 | 0.6 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 0.8 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.8 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.7 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 1.1 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 3.1 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.1 | 0.3 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 0.2 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.8 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.1 | 6.7 | GO:0008565 | protein transporter activity(GO:0008565) |
0.1 | 0.3 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 0.4 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.1 | 0.3 | GO:1990939 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) |
0.1 | 0.7 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 0.4 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.2 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.1 | 0.9 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.4 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 0.6 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 0.1 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) |
0.1 | 0.5 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 0.4 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 0.3 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 1.7 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.1 | 1.4 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.6 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.8 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.1 | 1.0 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 1.3 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 0.1 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.1 | 0.7 | GO:0008143 | poly(A) binding(GO:0008143) |
0.1 | 1.3 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.1 | 1.1 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.1 | 0.3 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.1 | 0.3 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 0.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.3 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 0.9 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 0.8 | GO:0043236 | laminin binding(GO:0043236) |
0.1 | 0.9 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 0.3 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.2 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.1 | 0.7 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.1 | 0.6 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 0.5 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 0.3 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 0.2 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.1 | 0.3 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.1 | 0.2 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.1 | 0.4 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 2.5 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.1 | 0.3 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 0.3 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 0.5 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 0.2 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 0.7 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.1 | 0.3 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.1 | 0.9 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.1 | 0.6 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.1 | 0.8 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.1 | 0.2 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.1 | 4.8 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 1.2 | GO:0000049 | tRNA binding(GO:0000049) |
0.1 | 1.8 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.1 | 1.5 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.1 | 0.2 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.1 | 0.2 | GO:0043734 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.1 | 0.6 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.1 | 0.4 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.1 | 0.6 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 0.7 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.2 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.1 | 0.4 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.1 | 0.4 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.2 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.1 | 1.0 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.6 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 0.4 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.1 | 0.5 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 1.2 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 0.2 | GO:0031705 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.1 | 0.7 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.1 | 0.1 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 0.1 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.1 | 0.5 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 1.7 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 3.8 | GO:0070035 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.1 | 10.2 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.3 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 1.2 | GO:0004532 | exoribonuclease activity(GO:0004532) |
0.1 | 0.2 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.5 | GO:0015179 | L-amino acid transmembrane transporter activity(GO:0015179) |
0.1 | 0.8 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.1 | 0.4 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 5.9 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.1 | 0.2 | GO:0045502 | dynein binding(GO:0045502) |
0.1 | 5.9 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 2.0 | GO:0016875 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.1 | 1.2 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 0.1 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.1 | 0.3 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 0.1 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 0.1 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.1 | 0.5 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.3 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 0.6 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
0.1 | 0.6 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 0.3 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 0.1 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 6.5 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.2 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.1 | 0.8 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.2 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 0.7 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.1 | 0.2 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.1 | 1.1 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 0.6 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 0.6 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.2 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.4 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.1 | 0.9 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 0.7 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.1 | 0.2 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.1 | 0.4 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 3.0 | GO:0044389 | ubiquitin protein ligase binding(GO:0031625) ubiquitin-like protein ligase binding(GO:0044389) |
0.1 | 1.9 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.8 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 0.1 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.1 | 7.6 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.1 | 0.4 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 0.6 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 0.2 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.1 | 0.7 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.1 | 0.2 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.2 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 2.1 | GO:0008134 | transcription factor binding(GO:0008134) |
0.1 | 0.3 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) |
0.1 | 0.2 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 0.3 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.1 | 0.7 | GO:0051117 | ATPase binding(GO:0051117) |
0.1 | 0.2 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 0.2 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 0.4 | GO:0043531 | ADP binding(GO:0043531) |
0.1 | 0.2 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.1 | 0.3 | GO:0030506 | ankyrin binding(GO:0030506) |
0.1 | 0.4 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 0.1 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 0.1 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 1.6 | GO:0050136 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 0.2 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 0.5 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 0.3 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.1 | 0.1 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.1 | 0.1 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.1 | 0.4 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 0.1 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 0.5 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.1 | 0.1 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.1 | 0.3 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.1 | 0.2 | GO:0030371 | translation repressor activity(GO:0030371) |
0.1 | 0.2 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 3.1 | GO:0016410 | N-acyltransferase activity(GO:0016410) |
0.1 | 0.5 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
0.0 | 1.1 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.0 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.0 | 0.9 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.0 | 0.2 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.0 | 0.3 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.3 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.0 | 0.2 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.0 | GO:0022884 | macromolecule transmembrane transporter activity(GO:0022884) |
0.0 | 0.5 | GO:0003711 | obsolete transcription elongation regulator activity(GO:0003711) |
0.0 | 0.1 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.2 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 0.5 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.0 | 21.9 | GO:0003723 | RNA binding(GO:0003723) |
0.0 | 0.3 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.2 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.2 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 0.3 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.0 | 0.4 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.0 | 0.3 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.0 | 0.3 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.0 | 0.2 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.0 | 3.6 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.0 | 0.4 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 0.7 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.0 | 0.3 | GO:0019864 | IgG binding(GO:0019864) |
0.0 | 0.2 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 0.1 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.0 | 4.4 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.0 | 0.7 | GO:0004386 | helicase activity(GO:0004386) |
0.0 | 0.5 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 1.3 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.0 | 0.1 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.0 | 7.4 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.1 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.5 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 9.1 | GO:0003712 | transcription cofactor activity(GO:0003712) |
0.0 | 1.0 | GO:0016563 | obsolete transcription activator activity(GO:0016563) |
0.0 | 0.1 | GO:0000217 | DNA secondary structure binding(GO:0000217) |
0.0 | 0.1 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.0 | 0.2 | GO:0016595 | glutamate binding(GO:0016595) |
0.0 | 0.1 | GO:0019104 | uracil DNA N-glycosylase activity(GO:0004844) DNA N-glycosylase activity(GO:0019104) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.0 | 0.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.0 | 0.2 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.0 | 0.8 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
0.0 | 0.1 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.0 | 0.7 | GO:0003682 | chromatin binding(GO:0003682) |
0.0 | 0.8 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.1 | GO:0004516 | nicotinate phosphoribosyltransferase activity(GO:0004516) |
0.0 | 0.0 | GO:0035173 | histone kinase activity(GO:0035173) |
0.0 | 1.2 | GO:0016564 | obsolete transcription repressor activity(GO:0016564) |
0.0 | 0.4 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.0 | 0.1 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.0 | 0.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.3 | GO:0005048 | signal sequence binding(GO:0005048) |
0.0 | 1.5 | GO:0004221 | obsolete ubiquitin thiolesterase activity(GO:0004221) |
0.0 | 0.1 | GO:0004607 | phosphatidylcholine-sterol O-acyltransferase activity(GO:0004607) |
0.0 | 0.6 | GO:1990782 | receptor tyrosine kinase binding(GO:0030971) protein tyrosine kinase binding(GO:1990782) |
0.0 | 0.1 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.1 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.0 | 0.3 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 0.1 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.0 | 0.2 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 1.1 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.3 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.0 | 0.1 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.0 | 0.3 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 0.4 | GO:0030528 | obsolete transcription regulator activity(GO:0030528) |
0.0 | 0.2 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.0 | 0.2 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.0 | 0.2 | GO:0010181 | FMN binding(GO:0010181) |
0.0 | 0.5 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.0 | 0.1 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.0 | 0.2 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.0 | 0.2 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.3 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.1 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.0 | 0.2 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.0 | 47.2 | GO:0003677 | DNA binding(GO:0003677) |
0.0 | 0.2 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.0 | 0.1 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.0 | 0.5 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.1 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.0 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.0 | 0.1 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 0.1 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.1 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.0 | 0.0 | GO:0060229 | lipase activator activity(GO:0060229) |
0.0 | 0.4 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.0 | 0.2 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.0 | 0.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.3 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.0 | 0.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 0.2 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.0 | 0.1 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.0 | 0.1 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 0.2 | GO:0005310 | dicarboxylic acid transmembrane transporter activity(GO:0005310) |
0.0 | 0.1 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.0 | 0.2 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.1 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.0 | 0.2 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.0 | 0.8 | GO:0004519 | endonuclease activity(GO:0004519) |
0.0 | 0.1 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.0 | 0.2 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.0 | 0.1 | GO:0009374 | biotin binding(GO:0009374) |
0.0 | 0.0 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.0 | 0.1 | GO:0042979 | ornithine decarboxylase inhibitor activity(GO:0008073) ornithine decarboxylase regulator activity(GO:0042979) |
0.0 | 0.4 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.0 | 0.8 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.6 | GO:0005507 | copper ion binding(GO:0005507) |
0.0 | 0.1 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.0 | 0.5 | GO:0032934 | sterol binding(GO:0032934) |
0.0 | 0.0 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 2.0 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.0 | 0.2 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.0 | 0.4 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.0 | 0.2 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.0 | 0.4 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.1 | GO:0016594 | glycine binding(GO:0016594) |
0.0 | 0.8 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.0 | 0.1 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.0 | 0.1 | GO:0015925 | galactosidase activity(GO:0015925) |
0.0 | 0.0 | GO:0031014 | troponin T binding(GO:0031014) |
0.0 | 0.1 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.0 | 0.4 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.0 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.3 | GO:0016853 | isomerase activity(GO:0016853) |
0.0 | 0.0 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.0 | 0.4 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.2 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.0 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.0 | GO:0000295 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.0 | 0.4 | GO:0019955 | cytokine binding(GO:0019955) |
0.0 | 0.2 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.0 | 0.1 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.0 | 0.0 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.0 | 0.1 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.0 | 0.1 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.1 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.0 | 0.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.1 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.0 | 0.1 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 0.1 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.0 | 0.1 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.1 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.0 | 0.0 | GO:0051636 | obsolete Gram-negative bacterial cell surface binding(GO:0051636) |
0.0 | 0.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.1 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
0.0 | 0.0 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.0 | 0.1 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.1 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.0 | 0.1 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.3 | GO:0019905 | syntaxin binding(GO:0019905) |
0.0 | 0.1 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.0 | 0.0 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.0 | 0.4 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.0 | 0.2 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.1 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.0 | 0.0 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.2 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.0 | 0.0 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.0 | 0.0 | GO:0016803 | hydrolase activity, acting on ether bonds(GO:0016801) ether hydrolase activity(GO:0016803) |
0.0 | 0.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.0 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.0 | 0.0 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.0 | 0.1 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.0 | GO:0042808 | obsolete neuronal Cdc2-like kinase binding(GO:0042808) |
0.0 | 0.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.0 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.0 | 0.0 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.0 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.0 | 0.0 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.0 | 0.0 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.0 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.0 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.0 | 0.0 | GO:0042393 | histone binding(GO:0042393) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 0.8 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.2 | 0.4 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 3.5 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 5.4 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.2 | 0.2 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.2 | 1.7 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.2 | 4.4 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.2 | 1.5 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 1.4 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 1.8 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 0.8 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 1.2 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 0.8 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 0.5 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 0.2 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 0.7 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 3.8 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 0.6 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 3.7 | PID AURORA B PATHWAY | Aurora B signaling |
0.1 | 0.9 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 0.4 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 3.8 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 1.8 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 0.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 0.7 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 3.5 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 1.6 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 2.4 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 1.1 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 2.7 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 2.5 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 1.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 0.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 2.6 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 1.4 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 0.7 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 1.0 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 0.9 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 1.1 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 0.4 | ST STAT3 PATHWAY | STAT3 Pathway |
0.1 | 3.6 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.1 | 3.5 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 3.6 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 1.3 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.1 | 1.5 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 1.0 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 3.3 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 1.6 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 0.9 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 2.4 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 0.2 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 1.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 0.5 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 0.9 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 1.4 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 0.4 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 1.3 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 0.3 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 0.3 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 1.4 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 0.1 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 0.5 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 2.1 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 0.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 1.5 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 1.3 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 1.8 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 0.1 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 2.2 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 1.4 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 0.9 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 0.7 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 0.5 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 0.2 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 0.2 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 1.0 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 0.1 | ST GAQ PATHWAY | G alpha q Pathway |
0.1 | 0.6 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 0.7 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 0.8 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 1.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.5 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.6 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.0 | 0.4 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 2.8 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.2 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 0.4 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.6 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 2.0 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 0.6 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.6 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.7 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.2 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 0.9 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.2 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 0.8 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.7 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.3 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 1.2 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.5 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.7 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.1 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 0.5 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.3 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.7 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.4 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.6 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 0.7 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.2 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.0 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.4 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.2 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 3.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.2 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.0 | 0.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.2 | PID FGF PATHWAY | FGF signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.3 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.2 | 0.7 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.2 | 0.2 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.2 | 2.2 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.2 | 1.8 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.2 | 4.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.2 | 3.3 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.2 | 3.0 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.2 | 1.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.2 | 1.3 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.2 | 1.3 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.2 | 3.3 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 4.6 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.1 | 3.6 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.1 | 1.9 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 1.4 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 0.3 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.1 | 0.9 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 0.6 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.1 | 0.9 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
0.1 | 2.2 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 7.1 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.1 | 2.9 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 0.1 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 0.8 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 1.7 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 1.4 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.1 | 1.6 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.1 | 2.3 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 0.6 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 0.3 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 0.1 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.1 | 0.3 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 2.3 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 1.1 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.1 | 1.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 1.6 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 2.0 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 2.4 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.1 | 1.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 2.6 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 0.4 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
0.1 | 0.1 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.1 | 2.1 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 0.2 | REACTOME ORC1 REMOVAL FROM CHROMATIN | Genes involved in Orc1 removal from chromatin |
0.1 | 1.1 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 3.6 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 0.9 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 1.1 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 2.0 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.1 | 1.3 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 0.2 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.1 | 1.1 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 5.1 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 0.9 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 1.3 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 0.1 | REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | Genes involved in Energy dependent regulation of mTOR by LKB1-AMPK |
0.1 | 1.0 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 1.9 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.1 | 0.6 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 0.1 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.1 | 0.6 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 1.3 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 0.1 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.1 | 0.2 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.1 | 0.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 1.6 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 8.8 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.1 | 1.4 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.1 | 4.3 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.1 | 0.4 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.1 | 0.6 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 0.9 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 1.3 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.1 | 1.4 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 1.4 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 1.4 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 2.8 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 1.3 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.1 | 1.4 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.1 | 3.1 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.1 | 0.4 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 1.0 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 1.4 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 0.4 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 0.1 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.1 | 0.9 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 0.4 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.1 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 1.0 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 0.8 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.1 | 0.4 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.1 | 1.0 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
0.1 | 0.5 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.1 | 2.0 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 0.1 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.1 | 2.6 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 8.1 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 1.1 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 1.2 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 0.6 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 1.2 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 0.9 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 0.3 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 0.3 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 1.3 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.1 | 1.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 0.7 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.1 | 0.3 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 1.0 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 0.2 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 0.3 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.1 | 0.5 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.1 | 0.2 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.1 | 1.3 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 0.1 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.1 | 2.5 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 0.6 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 2.4 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 1.5 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 1.7 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.1 | 1.5 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 0.9 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.1 | 0.8 | REACTOME TRANSLATION | Genes involved in Translation |
0.1 | 1.4 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.1 | 0.7 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 0.1 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.1 | 0.2 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 0.4 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 0.4 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 1.6 | REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION | Genes involved in RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription |
0.1 | 2.9 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.3 | REACTOME S PHASE | Genes involved in S Phase |
0.0 | 0.5 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.0 | 0.4 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.0 | 1.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 1.2 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.5 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 0.3 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.0 | 0.1 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.0 | 3.1 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.2 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.4 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.6 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.5 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 0.6 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 0.3 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.0 | 1.1 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.0 | 0.4 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 1.2 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.2 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 0.1 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.0 | 0.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 1.1 | REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | Genes involved in Class I MHC mediated antigen processing & presentation |
0.0 | 0.5 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 0.3 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
0.0 | 0.2 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.0 | 0.4 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.0 | 0.7 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.4 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.1 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.5 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.0 | 0.3 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.2 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.0 | 0.0 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.4 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 0.0 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 0.5 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.4 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.6 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.7 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.5 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.3 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 1.1 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.2 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.0 | 1.6 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.2 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 1.1 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 0.4 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 1.3 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 1.0 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.3 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.5 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 0.2 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.0 | 1.3 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.1 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.0 | 0.2 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 4.8 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.0 | 0.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.5 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.1 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.2 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.0 | 0.5 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.0 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.0 | 0.1 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 0.1 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 0.1 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.2 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.0 | 0.2 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.1 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.1 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.0 | REACTOME NEGATIVE REGULATION OF FGFR SIGNALING | Genes involved in Negative regulation of FGFR signaling |
0.0 | 0.1 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 0.2 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.0 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.1 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.1 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.0 | 0.2 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.0 | 0.3 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.0 | 0.1 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 0.0 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |